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Abstract 
 
Bone turnover has important impacts on bone health. The process modifies weak 
primary woven bone into the strong lamellar bone, repairs damage in bone, and 
maintains appropriate calcium homeostasis. The process relies heavily on controlled 
osteoclastic resorption by dissolution of mineral in the area undergoing remodelling. 
Bone degenerative diseases occur when the balance between bone resorption and 
deposition of new bone in the turnover process is altered. 
Bone is a nanocomposite material composed of a mineral phase (calcium phosphate) 
deposited within an organic matrix. In spite of the intensive research on the subject, the 
precise molecular structure of the bone mineral is still an open question. The 
incorporation of citrate within the mineral structure introduced by Davies et al has 
provided a more comprehensive structural model that could explain many observations 
in terms of the mineral structure. Based on this new structural model, a hypothesis has 
been proposed: that other metabolites similar to citrate can be incorporated into the 
mineral structure, and differences in metabolite incorporation cause fundamental 
differences in the physical properties of bone mineral. Thus, understanding the effect 
of metabolite incorporation on the physical properties of bone mineral will lead to 
insight into the molecular mechanisms of bone degenerative diseases and provide a link 
between bone quality and bone cell function that is currently missing. 
Chapter 1 provides overview of the bone composite and formation, and changes in its 
properties during ageing. The development of the mineral structural model is described 
and the shortcoming of existing models are assessed. 
Chapter 2 introduces the theoretical foundations of solid-state NMR spectroscopy, 
which is the primary analytical method employed in this study, followed by specific 
experimental techniques that have been used in this work. 
Chapter 3 describes the characterisation of seven different OCP-metabolite composites 
that have been synthesized in this work, and proposes possible structural models for 
 these composites based on an NMR crystallography approach to determine a structural 
model for one of the synthetic OCP-metabolite compounds, OCP-SUC. 
In Chapter 4, the dissolution rate of OCP-metabolites is measured in acidic solution to 
mimic the resorption process by osteoclasts and assess the possible effects of different 
incorporated metabolites on the solubility of bone mineral. 
Finally, Chapter 5 summarises the conclusions from the work and suggests the next 
steps that arise from this work to uncover the complete molecular structure of bone 
mineral and its variability in disease. 
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Chapter 1:                            
Introduction                             
 
Bone is the material that makes vertebrates distinct from other animals. It serves 
mechanical and homeostatic functions in the body, to provide structural support and 
protection for internal organs, enable locomotion and load-bearing, and act as a 
reservoir for calcium and phosphate ions.1,2 Two types of bone occur in the normal 
human skeleton: cortical and trabecular. 3,4 Cortical bone, which comprises 80% of the 
skeleton, is highly calcified and has a slow turnover rate. It is dense and compact, and 
so can withstand bending and torsional forces. It forms a coat on the outer part of all 
skeletal structures, and so provides mechanical strength and protection. The trabecular 
bone accounts for 20% of the skeletal mass, and occupies the inner part of the bone 
organ. It is less dense and more elastic than cortical bone, and involved primarily in 
metabolic/homeostatic functions. It achieves these functions with the help of a huge 
surface area (80% of the bone surface), and high turnover rate. It also contributes to 
mechanical support, typically in the vertebral bones. Despite the macroscopic and 
microscopic differences between the two types, they have nearly identical chemical 
composition. At molecular level, bone is a complex organic-inorganic composite 
material, which consists of three major components: organic material, inorganic 
mineral, and water. Each component provides properties essential for bone tissue to 
fulfil all its roles, which will be described in the following sections. 
1.1 Motivation of this study  
Bone turnover has important impacts on bone health. The process modifies weak 
primary woven bone into the strong lamellar bone, repairs damage in bone, and 
maintains appropriate calcium homeostasis. Bone turnover relies heavily on controlled 
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resorption by dissolution of mineral in the area undergoing remodelling. Dysfunctional 
bone remodelling is a key feature of bone degenerative diseases. For instance, 
osteoporosis is typically characterised by excessive bone matrix resorption compared 
with new bone deposition.5,6  
Bone mineral consists primarily of calcium phosphate, with a molecular structure 
similar to hydroxyapatite, and substituted by ionic species such as Mg2+, CO3
2−, HPO4
2−, 
F¯ etc. Recent work and older literature7–18 have highlighted the presence of metabolic 
acids in bone mineral, leading to the hypothesis on which this work is based: that 
differences in metabolite incorporation cause fundamental differences in the physical 
properties of bone mineral. Thus, understanding the effect of metabolite incorporation 
on the physical properties of bone mineral will lead to insight into the molecular 
mechanisms of bone degenerative diseases and provide a link between bone quality and 
bone cell function that is currently missing. 
1.2 Components of bone 
1.2.1 The organic scaffold 
The main function of the organic framework of bone is to provide flexibility to the bone 
structure, and it is the scaffold to which both bone cells and mineral adheres. The 
organic component constitutes ~20 wt% of bone tissue, of which 90 wt% is type I 
collagen.19 The collagen molecules are protein triple helices (tropocollagen), and 
packed together in staggered aggregates of 4-6 units to form microfibrils.20 These 
microfibrils are arranged into fibrils, in the form of a three-dimensional array, first 
proposed by Hodge & Petruska.21 So-called ‘hole zones’ are created within the 
microfibrils by staggered aggregation, in which non-collageneous protein (NCPs) 
binding sites predominate. The hole zones are aligned to form channels ~40 × 2 nm in 
dimension, which can accommodate and constrain mineral nanocrystals, and are 
thought to be the sites where initial mineralisation takes place with the deposition of an 
amorphous calcium phosphate (ACP) phase. 
1.2.2 The inorganic mineral 
The bone mineral, which contributes to 70 wt% of bone, primarily provides elasticity, 
strength and toughness against stress and force, for bone to fulfil its mechanical role. It 
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exists in the form of calcium phosphate nanoparticles, often described as a poorly 
crystalline, calcium-deficient, hydroxyl-deficient, heavily-substituted and non-
stoichiometric apatite, or biological apatite.22,23 The nanoparticles are ~50 × 25 nm 
platelets consisting of close packed lamellae, with thicknesses of between 2.5 and 4 
nm.11 The nanoparticle length corresponds roughly to the dimensions of the hole zones 
of the collagen fibrils (~40 × 2 nm), and the thickness is approximately two 
hydroxyapatite unit cells. Such thin platelet structures provide a huge surface area to 
volume ratio, meaning that the bone mineral can interact effectively with its 
environment.24  
While most of the literature has reported that the bone mineral particles are similar in 
size to the hole zones in the collagen fibrils, there is evidence of larger crystallites (up 
to 226 nm) which cannot be accommodated in a single hole zone.25 Studies of 
deproteinated bone tissue shows that the overall structure of the mineral is still 
maintained as a network, suggested that the mineral phase is continuous throughout the 
fibril.26 Therefore, bone is not simply a mineral-reinforced collagen matrix, but a 
composite network of the two materials.27 
 
Figure 1.1. Crystal structure of stoichiometric HAp. Left: atoms within a unit cell. Right: 
The hexagonal representation of HAp, with 2×2 unit cells. The centre of the structure 
is the hydroxyl channel of HAp. 
The composition of native bone mineral does not correspond to the lattice structure of 
stoichiometric HAp, due to numerous lattice substitutions and ionic vacancies,28 and 
regions containing highly hydrated, disordered material, unrelated in composition to 
HAp. Evidence for the hydrated disordered region comes, among other sources, from 
1H-31P FSLG HETCOR spectra (see Section 2.2.8 for experimental detail) which show 
a narrower range in the 31P chemical shift dimension for the 1H signal of hydroxide ion 
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than the 1H signal of water. The centre-of-mass of the hydroxide 1H signal is also 
slightly shifted to higher frequency than the centre-of-mass of the water signal in the 
31P dimension. This suggests that hydroxide ions only represent a small proportion of 
the mineral, and are most likely to be at the internal apatitic region of the mineral 
crystallites rather than the more disordered hydration layer.29,30 31P ssNMR 
spectroscopy has shown that a significant proportion of the HPO4
2- environments 
present in bone mineral are located at the surface of the crystal, while the PO4
3− ions 
are concentrated in the core of the mineral crystal,31 which suggested the nanocrystals 
of bone mineral comprise a highly-crystalline core surrounded by disordered hydrated 
region (Figure 1.2). 1H MAS NMR of deproteinated bone at 225°C indicates tightly 
bound structural water molecules in the mineral, also observed in carbonated apatite.28 
These structural waters may occupy the vacancies created by substitutions and defects 
in the mineral structure, and may stabilise local structure through hydrogen bonding 
with surrounding ions. 
 
 
Figure 1.2. Schematic representation of bone mineral platelet. Each platelet consists 
of a closely packed lamella structure, with each lamella having an apatitic core, 
surrounded by the hydrated, disordered region. 
1.2.3 Water 
Water contributes at least 10 wt% to the mass of bone,22,28 and is present everywhere: 
inside the collagen fibrils, between the organic-mineral interface, with a significant 
quantity trapped inside the mineral. There is evidence that water occupies calcium 
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vacancies and hydroxyl channels to stabilise the mineral nanocrystals.28 Some of the 
water molecules are strongly bound to the mineral, as shown by the fact that heating 
deproteinated hydrated cortical bones at 225ºC only removes 63% of the water.28 The 
proximity between mineral orthophosphate and water was suggested as the origin of 
the HPO4
2− signal observed in HETCOR experiments, where the proton is rapidly 
exchanged between the orthophosphate and the water.32 The dehydration of the bone 
reduces the distance between the organic framework and the mineral surface, and leads 
to the disappearance of the platelet structure of the mineral (stacks of platelet collapse 
into bulk crystal).33 These waters are thought to play important roles in lubricating the 
bone against stress, either via movement or as a sacrificial layer, and are crucial in 
mediating the interaction between the organic and mineral phase, and helping to 
determine the nanostructure of the mineral.28 
1.3 Bone formation 
There are two main stages of bone formation: primary osteogenesis, which forms 
woven bone, and secondary osteogenesis, which forms lamellar bone. The two stages 
display substantially different mechanisms of formation.34,35 In primary osteogenesis, 
collagen is laid down in the form of small, loose fibril bundles, without long-range 
order. Mineral deposited on this primary matrix is very porous at the micron level, 
causing the woven bone to be mechanically weak. In the secondary stage, the woven 
bone is remodelled into lamellar bone, which has a regular parallel alignment of 
collagen fibrils as the mineralisation matrix, and the final material is mechanically 
strong. Woven bone can be laid down rapidly, and is only found in new bone growth 
such as fetal bones or the first bone to grow in healing fractures (and in some diseases, 
such as Paget’s disease). Because woven bone only acts as the initial template for 
remodelling to lamellar bone, and does not support any of the mechanical functions of 
bone, hereafter “bone” always refers to the lamellar type.  
1.3.1 The bone remodelling process 
Bone is a dynamic, continually renewed tissue. Bone remodelling is a complex process 
requiring interactions between different bone cells, and is regulated by many 
biochemical and mechanical factors.36,37 It is vital to maintaining healthy bone, because: 
1) it allows the modification of primary woven bone into the lamellar bone; 2) it 
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removes microfractured bone and repairs disruptions in cell, collagen and mineral 
structures; 3) it maintains appropriate calcium homeostasis.  
Remodelling is performed by two key bone cell types: osteoclasts and osteoblasts. 
Osteoclasts are multinucleated cells that dissolve bone mineral and remove the collagen 
matrix.38,39 Osteoblasts, derived from mesenchymal stem cells, synthesise the collagen 
matrix and facilitate mineralisation.40 Another important cell type, osteocytes, are 
osteoblasts that have become trapped in the osteoid, respond to bone tissue strain and 
initiate remodelling by recruiting osteoclasts to the damaged site.41 
1.3.2 Phases of remodelling 
Remodelling comprises four phases (Figure 1.3). 
1. Activation, initiated by factors such as microfracture, sensing of mechanical 
loading by osteocytes, or release of biochemical messengers (such as insulin 
growth factor-I, or tumour necrosis factor-α) in the local bone environment.42 
These factors activate the lining cells, which are quiescent osteoblasts, to 
increase the expression of RANKL (receptor activator nuclear κB ligand) on 
osteocyte cell surface. RANKL interacts with its receptor RANK (receptor 
activator nuclear κB), on the surface of pre-osteoclasts, which triggers fusion 
and differentiation of pre-osteoclasts to osteoclasts.39,43–45 
2. Resorption, initiated by osteoclasts binding to the bone surface. The osteoclasts 
first acidify the bone matrix to dissolve the mineral by releasing protons into 
the area to be resorbed via an electrogenic proton pump.46–48 The resorption area 
needs to be a closed space, which is achieved by rearrangement of osteoclast 
cytoskeleton to form ‘ruffled membrane’ and formation of an actin ring, which 
is an isolated extracellular environment between the cell membrane and the 
bone surface.46,47,49 After dissolution of the mineral, osteoclasts release 
lysosomal enzymes to proteolyse the organic component of the bone. Once the 
resorption is complete, osteoclast apoptosis takes place, which is regulated by 
osteoprotegerin (OPG), to prevent excessive bone resorption.50,51  
3. Reversal, in which macrophage-like “reverse cells” remove any debris produced 
during resorption, and prepare the surface for new osteoblasts to begin bone 
formation and provide signals for osteoblast differentiation and migration.1,52  
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4. Formation, in which osteoblasts are recruited to the resorbed site after the 
resorption is complete, lay down new organic matrix, and then promote 
mineralisation.36 
Between 60 to 80% of the osteoblasts involved in the formation phase will undergo 
apoptosis within 200 days of recruitment.53,54 Some of the osteoblasts become quiescent 
bone-lining cells which await activation signals of the remodelling process. The 
remaining osteoblasts are surrounded by mineral and become osteocytes.  
The remodelling process requires a fine balance between bone resorption and bone 
formation in order to maintain a healthy bone mass.55 This involves complex regulatory 
pathways, failure of which leads to diseases such as osteopetrosis,52 where inefficient 
resorption of bone leads to bone mass increase, causing impairment of bone marrow 
development, visual and hearing deterioration and osteosclerosis.  
 
Figure 1.3. Schematic representation of the bone remodelling process. The pre-
osteoclasts differentiate into osteoclasts (activation phase), and then resorb bone at pH 
4.5 (resorption phase). After bone matrix resorption, osteoclast apoptosis takes place, 
and ‘reverse cells’ prepare the resorbed surface and release signals for osteoblast 
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differentiation and migration (reversal phase). The osteoblasts produce new bone 
matrix and promote mineralisation (formation phase), and complete the bone 
remodelling process. 
1.3.3 Mineralisation mechanism 
Mineralisation is the process of which the mineral crystals are deposited inside and 
around collagen fibrils. Three different bone biomineralization pathways have been 
proposed, all of which may be simultaneously involved, although the exact process 
remains unknown. 
The passive formation model proposes that mineralisation of the collagen matrix is 
facilitated and regulated by non-collagenous proteins (NCPs), without the involvement 
of cells. NCPs account for 10 wt% of the organic material in bone, and many are highly 
charged with abundant glutamate and aspartate carboxylates, and so are potential 
calcium ion chelators.56 It has been reported that NCPs inhibit apatite formation in 
solution, but promote calcium phosphate nucleation when bound to a substrate such as 
collagen.27 The charged groups on NCPs are proposed to concentrate the calcium and 
phosphate ions from the solution around collagen fibrils, and enable the nucleation 
process and further crystal growth on the fibrils.57   
A different model, the ‘ACP theory’,58 proposes that mineralisation begins with the 
formation of an amorphous calcium phosphate (ACP) precursor phase delivered to the 
hole zones in the collagen fibril, which then matures into bone mineral. This mechanism 
is thought to be responsible for the formation of the calcium carbonate biomineral in 
invertebrates.59,60 
Another widely accepted model involves “matrix vesicles” (MVs) budded off from cell 
plasma membranes of osteoblast.61 MVs are proposed to regulate the phosphate to 
pyrophosphate ratio in the pre-mineralised extracellular space, which is thought to 
trigger mineralisation.62 The MVs contain two key enzymes which regulate this ratio: 
NPP1, which hydrolyses nucleoside triphosphates to increase the extracellular 
concentration of pyrophosphate; and TNAP, which hydrolyses pyrophosphate to 
produce phosphate. Elevation of the phosphate concentration in the extracellular space 
promotes the mineralisation to take place.63–66 The MVs are also proposed to deliver 
the Ca2+ and Pi ions to the mineralisation front, nucleate and grow mineral crystals. 
Chapter 1: Introduction                                                     
 
9 
 
However, studies on MVs have all been carried out on tissues that do not natively 
mineralise, namely cartilage, tendon or in vitro models; there is no in vivo evidence that 
MVs are responsible for the mineralisation of bone. 
As bone mineral is a complex material it would be expected to have complex and well-
regulated formation mechanisms. All three models are supported by experimental 
evidence, all with certain limitations. Like the pieces of a jigsaw puzzle, each is likely 
to only describe part of the overall picture.  
1.4 Effect of ageing 
1.4.1 Overview 
The ability of bone to perform its mechanical and biochemical functions becomes 
impaired with ageing. Bones becomes more fragile, and the ion storage potential is 
often reduced. Studies on cortical bone from older subjects show that ageing affects all 
parameters (permanent deformation, viscous behaviour, porosity, mineral and collagen 
content and collagen crosslinks), except elastic stiffness.67  
With ageing, resorption by osteoclasts begins to exceed bone formation by osteoblasts, 
so the mass of bone deposited with each remodelling cycle decreases.68 This is thought 
to be because of a decline in the number of osteoblast precursors, or a reduction in 
osteoblast lifespan. It is hypothesized that the remodelling of the local bone tissue is 
regulated by the osteocyte apoptosis at the site of canalicular network disruption.69 With 
ageing, there is an increase in osteocyte apoptosis, which contributes to bone weakening 
by the formation of areas of micropetrosis,53,54 where the lacunae are filled with mineral, 
changing the dynamics of fluid flow through the lacunocanalicular network. This 
disruption of the lacunocanalicular network will then decrease ability to repair 
microfractures. Bone toughness is reduced by such damage, which can be caused by 
repetitive loading. The damage may start with combinations of disruption in mineral 
crystallites, organic-mineral interface, collagen fibrils, and osteocytes. But it can only 
be repaired by remodelling, and this repair process becomes less efficient with ageing, 
and so the bone becomes weaker. 
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1.4.2 Collagen 
With ageing, there is a considerable increase in the rate of non-enzymatic cross-linking, 
and a decrease in the enzymatic cross-linking in collagen.70 The consequence is a 
decrease in bone strength and toughness and stimulation of crack propagation from 
microfracture.71 The cross-links also affect collagen mineralisation. The accumulation 
of advanced glycation end-products (AGEs, which are responsible for the non-
enzymatic cross-linking) can only be reversed by bone resorption; the presence of cross 
links accelerates osteoclast resorption, while reducing the formation rate by osteoblasts, 
leaving behind a porous structure which contributes to bone weakening.72 
1.4.3 Mineral 
The mineral in bone is the key component providing elasticity, stiffness and strength to 
the tissue for it to resist deformation and stress. The mineral content of bone increases 
during growth and development of the organism, and then declines with ageing, as part 
of the general reduction in bone mass. As the mineral content increases, the ability of 
bone to withstand stress increases exponentially, as well as brittleness.73 X-ray 
diffraction analyses on homogenised iliac crest biopsies show that the bone mineral 
crystallites increase in size and crystallinity during the first 25-30 years, and thereafter 
decreases. Wavelength-dispersive X-ray fluorescence applied to the same samples 
shows that carbonate content of bone mineral increases with ageing, along with a 
decrease in phosphate and increase in hydroxyl content.31,74–76 The increase in the 
crystal size and crystallinity leads the mineral towards stoichiometric HAp composition. 
An in vitro study showed that osteoclasts preferentially resorb older bone,77 which 
would accelerate the remodelling process and, as the solubility of bone decreases as 
crystallinity of mineral increases, more crystalline mineral may be left behind during 
bone remodelling and accumulate. 
1.4.4 Osteoporosis 
Osteoporosis is a disease in which the density and quality of the bone is reduced. The 
bone becomes more porous and fragile (similar to the effect of ageing), which increases 
the probability of fracture.78–80 There are no symptoms until the first fracture occurs, so 
it also known as the ‘silent disease’. There are 1 in 3 women and 1 in 5 men over age 
50 in the world at risk of osteoporotic fracture,81,82 and spinal and hip fractures in 
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particular may result in serious consequences such as loss of height, deformity, loss of 
independence, or even death.83–86  
Osteoporotic bones are thinner, with increased mean crystal size, collagen maturity, 
and carbonate content, compared to age-matched controls.78 Preventive measures 
include taking calcium and vitamin D supplements (calcium alone has no observable 
effect), and avoiding smoking and alcohol.87 The most common treatment is with 
bisphosphonates,88,89 which bind at the bone mineral surface and inhibit resorption by 
osteoclasts.90,91 This leads to a lower bone turnover rate, and stabilises bone mass and 
microarchitecture reducing fracture risk. As with all drugs, bisphosphonate use causes 
side effects, most commonly gastrointestinal (esophageal irritation, dysphagia and 
heartburn). Some patients suffer from hypocalcemia due to reduced calcium release 
resulting from inhibition of bone resorption. There is also an association between the 
use of bisphosphonates and osteonecrosis of the jaw,92 and atypical femur fractures.93 
Moreover, bone tissue microdamage such as microfracture and non-enzymatic collagen 
cross-linking can only be repaired by remodelling. Prolonged suppression of bone 
resorption (and formation, which is a coupled process) by bisphosphonates will result 
over time in accumulation of microdamage, and hence weak and brittle bone. 
Understanding the bone mineral structure at the molecular level would enhance our 
knowledge of the basis of mechanical properties of the bone, and be relevant to the 
design of bone replacement and treating diseases. A significant step towards this will 
be constructing a detailed molecular model of bone mineral.  
1.5 Model of bone mineral 
The first model of bone mineral was proposed in 1926 by Dejong94 as hydroxyapatite 
(HAp), with molecular formula of Ca10(OH)2(PO4)6. HAp can accommodate many 
substitutions to give non-stoichiometric HAp (Na+, K+, Mg2+ for Ca2+; CO3
2− and 
HPO4
2− for PO4
3−, and F¯, Cl¯, CO3
2− for OH¯), and this is true of biological HAp. 
Later studies19 estimated 5-8 wt% carbonate, so the mineral was then classified as 
carbonate apatite (CHA). Carbonate ions can replace the hydroxide ions or the 
phosphate groups, resulting in so called type A or type B (the predominant carbonate 
substitution) CHA respectively. Charge balance in response to these substitutions 
requires the formation of vacancies or replacement of other ions.95 FTIR and Raman IR 
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spectroscopy cannot distinguish hydroxyl ions and water in bone mineral, but solid-
state NMR spectroscopy estimates that bone mineral only contains 20% OH¯ relative 
to stoichiometric HAp. Since the small nanocrystallite size does not favour the hydroxyl 
channel energetically,96 these hydroxyl ions are more likely to be in the interior of the 
nanocrystallite, where they can hydrogen-bond to nearby ions.28 The presence of 
hydrogen phosphate HPO4
2− in bone mineral has been demonstrated by solid-state 
NMR and FTIR.97,98 The chemical environment of the HPO4
2−groups appears to be 
unique to bone mineral, as they show similar 31P isotropic chemical shifts as the HPO4
2− 
in OCP, but the 31P chemical shift anisotropy of HPO4
2− in brushite. It has been 
suggested that these unique HPO4
2− groups in bone mineral are due to rapid exchange 
of a proton between water and PO4
3- groups; they have also been shown to be located 
at the surface of the mineral crystallites. The molar ratio of HPO4
2- and PO4
3- decreases 
as the mineral ages.31,99 This may due to an increase in the size and crystallinity of the 
mineral crystallites, and hence a decrease in crystallite surface area. At this stage, the 
model for bone mineral may be described as carbonate apatite with substitution of 
HPO4
2− and water. 
This model gives an adequate description of the chemistry of the mineral component of 
bone satisfying the experimental observations of the presence of carbonate, hydrogen 
phosphate and water, but it is inadequate to completely account for the physical form 
of the mineral structure. The thickness of the platelets corresponds to only a few unit 
cells of the HAp structure, which would favour further growth of the crystallite due to 
high surface energy. In vitro studies have shown that bone non-collagenous proteins 
such as osteocalcin and osteopontin100 can affect HAp crystal formation and 
growth,101,102 but these proteins are not sufficiently abundant to bind to all the crystallite 
surfaces, so another mechanism to control platelet size is necessary. HAp is the most 
thermodynamically stable form of calcium phosphate,103 therefore given time, any 
calcium phosphate material would gradually turn into HAp, so the internal lamellar 
structure of bone mineral particles would collapse into a single block of crystalline HAp 
under normal circumstances. The thin platelet structure of bone mineral with internal 
lamellae cannot be explained by this model, so something more comprehensive is 
required, and can also provide link between bone quality and cell function and health. 
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Metabolites in bone mineral 
Bone contains 2 - 5 wt% citrate,12,104 which corresponds to ~70% of the total citrate 
content of the body. Citrate is a central metabolite in the citric acid cycle, a metabolic 
pathway in which acetyl-CoA (a glycolysis product) is oxidised to produce energy.105 
Citrate has high affinity for calcium, and has been shown to affect nucleation and 
growth of HAp in simulated body fluids.106 In 1953, Dixon and Perkins107 suggested 
that mineralisation of bone is influenced by an increase in the local concentration of 
citrate, and these citrate anions could be co-precipitated into the bone mineral. An in 
vitro study has found that osteoblasts are specialised to produce high level of citrate, 
which may be used to maintain the plasma citrate levels.9,12 The unusually high level 
of citrate in bone, its affinity for calcium, and de novo production of citrate in bone, all 
point to the possibility that that citrate plays important roles in bone formation and 
contributes to its functional properties.  
In 2010, Hu et al.15 used solid-state NMR spectroscopy to show that citrate is strongly 
bound to the bone apatite nanocrystals. They proposed that citrates are bound to the 
surface of the bone mineral platelets, which stabilises nucleation during the mineral 
formation process and subsequently modulates crystal growth, leading to a model for 
bone mineral of HAp with surfaces capped by citrate anions. Although this model 
incorporates citrate into the bone mineral structure, the model still lacks tightly bound 
water and fails to explain the internal lamellar structure observed in native bone mineral. 
Davies et al.11 in 2012 proposed that the citrate molecules can be present within the 
bone mineral lattice structure. They proposed an octacalcium phosphate (OCP) model 
of the hydrated layer, with core hydroxyapatite (Figure 1.4). In this model, citrate 
anions are bound to calcium in the disordered hydration layer as a bridge across more 
ordered layers. This model accounts for all major chemical species found in bone: 
calcium, orthophosphate, hydrogen phosphate, water and citrate. It naturally includes 
the disordered hydrated regions in the mineral, and explains the formation of the 
internal lamellar structure of mineral platelets due to inclusion of citrate. 
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Figure 1.4. Model for bone matrix organisation, new model proposed by Davies et al.11 
has lamellae with an apatitic core (see Figure 1.2), surrounded by a structure similar 
to octacalcium phosphate – citrate as the disordered hydrated region covering the 
lamellae surface. Figure courtesy of Professor M. J. Duer.  
Besides citrate, there are other structurally similar metabolites, such as succinate and 
lactate, produced in every cell, and able to bind to calcium. If citrate can be incorporated 
into the mineral structure, then other carboxylate metabolites may also be part of the 
bone mineral structure.  
The incorporation of lactate into mineral structures is not unknown to nature. 
Freshwater turtles take up and store lactate in their skeleton during anoxic 
submergence.17,108 The increase in freshwater turtles’ skeletal lactate concentration far 
exceeds that of a simple solution of lactate in the water of bone. This suggests that the 
lactate is incorporated into the bone mineral structure itself, accompanied by a cation 
or exchange with another anion, to maintain electroneutrality.108 Lactate accumulation 
in bone has been observed in other vertebrates, such as caiman (Caiman latirostris), 
frog (Rana pipiens) and armoured catfish (Liposarcus paradalis), after submergence, 
exhaustive exercise or hypoxic exposure.17  
The mammal bone cells produce a lot of lactate through glycolytic pathways, and it is 
the main acid produced by bone cells.7 Cellular production of lactic acid lowers the pH 
in bone, and the lactate concentration gradients between bone and blood controls the 
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calcium flux between the bone mineral and the circulation,8 which is important in the 
homeostasic function of bone. 
Small metabolites present in bone would be expected to be incorporated into the bone 
mineral structure similarly to citrate, namely in the hydrated layer of the mineral 
chelating calcium and binding water. Substituting different metabolites into the bone 
mineral would be expected to affect bone mineral properties, particularly solubility. For 
instance, the incorporation of smaller lactate anions might result in denser mineral 
phases. The density and the crystallinity of the mineral phase will affect its solubility, 
and ‘impurities’, such as any metabolites, will alter these two properties with likely 
changes to the solubility of the mineral phase. If the bone mineral model with citrate is 
considered as “normal” bone mineral, then incorporation of the smaller lactate anion 
may lead to higher density mineral phases, so ‘lactate’ mineral may be less soluble than 
the normal bone. 
As discussed earlier, the remodelling process requires a balance between resorption by 
osteoclasts and formation by osteoblasts. If the mineral is too soluble, then the 
resorption process will be much faster, leaving more void than the osteoblasts can fill, 
leading to porous bone, and thereby contributing to osteoporosis. On the other hand 
reduced mineral solubility may have the opposite effect, and inefficient bone resorption 
will contribute to osteopetrosis. 
1.6 Summary 
Bone matrix is a complex nano-composite material, composed primarily of collagen 
matrix interacting with mineral particles, which fulfils important mechanical and 
homeostatic functions in the body. Bone matrix is dynamic and undergoes constant 
remodelling, which in healthy bone depends on a fine balance between resorption by 
osteoclasts and formation by osteoblasts. During ageing, many changes occur to the 
bone cells, collagen matrix and the mineral crystallites, and the symptoms of bone 
diseases such as osteoporosis parallel the effects of ageing. The current model of bone 
mineral structure consists of an apatitic core of hydroxyapatite, and a disordered 
hydration layer containing water and citrates.  
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This work hypothesizes that differences in metabolite incorporation into the mineral 
component cause fundamental differences in the physical properties of bone mineral, 
which have consequential effects on the bone matrix resorption process. Thus, 
understanding the effect of metabolite incorporation on the physical properties of bone 
mineral will provide to insight into the molecular mechanisms of bone degenerative 
diseases and provide a link between bone quality and bone cell function that is currently 
missing. 
To test the hypothesis, several different octacalcium phosphate – metabolite composites 
are synthesized in this work, and used as model systems in which to explore the 
differential effects of different metabolites on the calcium phosphate mineral structure 
and solubility; structure is relevant to mechanical properties whilst solubility is the 
essential parameter in bone mineral resorption. A combination of techniques such as 
solid-state nuclear magnetic resonance (ssNMR) spectroscopy, powder X-ray 
diffraction (PXRD), electron microscopy (EM) and density functional theory (DFT) 
calculations are applied to characterise and create structural models for these synthetic 
composites. Study of these model systems provides information on the change in bone 
mineral structure through incorporation of different metabolites, and are used to explain 
mineral structural differences known to occur in bone. The same model systems are 
also used to investigate the effect of metabolite incorporation on dissolution rate, which 
is crucial in the bone resorption process, and can provide insights of bone degenerative 
disease at molecular level.   
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Chapter 2:                                                                                          
Solid-State Nuclear Magnetic 
Resonance (ssNMR) Spectroscopy 
 
Solid-state nuclear magnetic resonance spectroscopy was used as the primary 
characterisation technique to investigate the OCP-metabolite composites. The great 
advantages of using ssNMR spectroscopy to study bone mineral structure is that the 
technique is able to provide structural information at an atomic level in samples without 
long-range order, and no special sample preparation which could disrupt the native state 
is required. The abundance of 31P nuclei in the mineral phase enables easy access to 
mineral structural information with ssNMR. In addition, 13C and 31P can provide 
information about the relationship between the organic and mineral phases, as well as 
the incorporation of organic molecules which is the focus of this study. 
This chapter introduces the theoretical foundations of ssNMR beginning with the 
nuclear spin interactions and how these interactions provide structural information, 
followed by the specific experimental techniques that have been used in this work. 
2.1 Nuclear spin interactions 
2.1.1 Nuclear spin and magnetic field 
Matter is made of atoms, and atoms contain nuclei. There are four important physical 
properties that every nucleus has: mass, charge, spin and magnetism. The last two 
properties enable study of molecular environments by NMR spectroscopy. 
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Nuclei process an intrinsic property called nuclear spin, I, which is a vector quantity 
that is parameterised by the spin quantum number, I. The magnitude of the quantity is 
determined by the number of protons and neutrons in the nucleus and can be integer or 
half integer (and normally less than 4). In quantum mechanics, the nuclear spin has 
quantised energy levels, and is specified by the magnetic quantum number, m. The 
possible values of m range from –I to +I in integer steps, and there are   2I + 1 different 
values, which generates 2I + 1 energy levels, which in the absence of an external 
magnetic field, are all degenerate. The application of a magnetic field splits these 
energy levels to have slightly different energies. Such interaction is called the Zeeman 
interaction, and the separation of these energy levels is known as Zeeman splitting.109 
Only transitions with Δm = ±1 are allowed by the selection rules, and spin transitions 
between these Zeeman energy levels are the basis of NMR spectroscopy which with 
current available magnets is performed in the radio frequency reguion. Since there will 
be (2I+1) energy levels for a given value of I, nuclei with I = 0 have only one energy 
level. Hence no spin transition is possible, and they cannot be observed with NMR 
spectroscopy and are said to be NMR inactive.   
Each nucleus has a magnetic moment, µ: 
𝝁 = 𝛾𝑰 ,                                                           (2.1) 
where γ is the gyromagnetic ratio, a constant for a given type of nucleus, and I is the 
nuclear spin of that nucleus. In the absence of a magnetic field, the magnetic moment 
of each nucleus points in a random direction due to random thermal motion. When an 
external magnetic field, B, is applied to the system, the energy of nuclear spins are 
minimised if they are align with the applied field. Although thermal motions cause a 
distribution of nuclear spin orientations rather than perfect alignment with the field, 
there is still a preference for spins to orient with the field, which causes net nuclear 
magnetisation, or bulk magnetisation, M. This bulk magnetisation will precess around 
B at a rate ω = −γB. In NMR spectroscopy, a large, static and homogeneous magnetic 
field B0 is applied along the z-axis of the laboratory frame of reference, the rate of 
precession of magnetisation about the field is defined as the Larmor frequency, ω0 =
−γB0 . Unlike other spectroscopy, where the frequency or wavelength of the 
absorptions is quoted, NMR spectroscopy records chemical shift (δ) in parts per million 
(ppm): 
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𝛿(𝑝𝑝𝑚) = 106 ×
𝜐−𝜐𝑟𝑒𝑓
𝜐𝑟𝑒𝑓
 ,                                                (2.2)                            
where υ is the frequency of the observed absorption (𝜐 =
𝜔
2𝜋
, in Hz), υref is the frequency 
of an agreed reference compound. The use of the chemical shift scale is to make the 
analysis of the spectrum independent of the field strength at which the spectrum was 
recorded.  
In a molecule, most atoms are in different local environments, and the electron clouds 
and internuclear magnetic dipole interactions in these environments will give rise to 
slightly different precession frequencies. For ssNMR, the observed frequency is 
influenced by several interactions, and can be expressed as the Hamiltonian: 
𝑯 = 𝑯𝒁 + 𝑯𝑪𝑺 + 𝑯𝑫 + 𝑯𝑸 ,                                            (2.3) 
Where HZ is the Zeeman interaction, HCS is the chemical shielding interaction, HD is 
the magnetic dipole-dipole coupling interaction, and the HQ is the electric quadrupole 
coupling interaction. 
The Zeeman interaction, which depends on the type of nuclei, has the largest effect on 
the precession frequency; as the gyromagnetic ratio is different for different nuclei, 
each will have a different Larmor frequency. Chemical shielding is caused by electrons 
surrounding the nucleus, and it provides information about local electronic structure. 
Assignment of frequency for the same element due to chemical shielding can provide 
much useful structural information directly. The dipolar interaction is caused by 
interaction between two nuclear magnetic moments, and it is the major cause of line-
broadening. In ssNMR spectra, the manipulation of this interaction can provide 
information on internuclear distances within a molecule or material. The quadrupole 
coupling is caused by the electric quadrupole moment of quadrupolar nuclei (𝐼 >
1
2
 ).  
Apart from the Zeeman interaction HZ, all other interactions are caused by internal 
magnetic fields, and can be written in the form: 
                𝑯 = −𝛾ℏ?̂? ⋅ 𝑩𝑳𝒐𝒄                                                     (2.4)   
          = −𝛾ℏ?̂? ⋅ 𝑨𝑳𝒐𝒄 ⋅ 𝑱 ,                                               (2.5) 
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where the local field, BLoc, generated by the nuclei, can be written in the form of dot 
product between a second-rank coupling tensor, ALoc, which describes the nuclear spin 
interaction and orientation, and a vector J, which is the source of the local magnetic 
field. 
2.1.2 Chemical shielding 
The electrons in the molecule interact with the external magnetic field, and cause 
variation in local magnetic field experienced by nuclear spins. This type of interaction 
is called chemical shielding. There are two components of the shielding effect: 
diamagnetic and paramagnetic. 
When electron clouds interact with an external magnetic field, an induced current is 
generated, and the current in turn produces a local magnetic field which opposes the 
applied field, hence shields the nucleus. This reduction in the local field is known as 
the diamagnetic component. 
The electron distribution can also be distorted by the external magnetic field, and can 
be described as mixing between the ground and excited electronic state. This can 
introduce paramagnetic properties of excited electronic states into the ground state, and 
generates a local field which supports the external field, and hence de-shields the 
nucleus. This enhancement in local field is known as the paramagnetic component. 
The local magnetic field, BLoc, caused by chemical shielding can be related to the 
external magnetic field, B0, by  
𝑩𝑳𝒐𝒄 = 𝝈 ∙ 𝑩𝟎                                              (2.6) 
where σ is the shielding tensor, which is a second-rank Cartesian tensor, represented by 
a 3×3 matrix in a specified axis frame. The shielding tensor can be written as the sum 
of the diamagnetic term and paramagnetic term which in turn can be written in terms 
of the ground state electronic wavefunction and the excited state wavefunction 
respectively. 
The shielding tensor describes the effect of chemical shielding due to B0, and this effect 
is molecular orientation dependent with respect to the direction of B0. It is possible to 
choose an axis frame such that σ is described as a diagonal tensor. This axis frame is 
called the principal axis frame (PAF), and the diagonal values: 𝜎𝑥𝑥, 𝜎𝑦𝑦, and 𝜎𝑧𝑧 are 
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known as the principal shielding values. The PAF is determined by the electronic 
structure which surrounds the nucleus of interest, and is fixed with respect to the 
molecule. The orientation dependence between the PAF and B0 is (3cos2 θ − 1), where 
θ is the angle between the zPAF-axis and B0. 
The three chemical shielding parameters can be determined by the principal shielding 
values: 
𝜎𝑖𝑠𝑜 =
1
3
(𝜎𝑥𝑥 + 𝜎𝑦𝑦 + 𝜎𝑧𝑧)                                              (2.7) 
∆  = 𝜎𝑧𝑧 − 𝜎𝑖𝑠𝑜                                                      (2.8) 
𝜂 =
𝜎𝑥𝑥−𝜎𝑦𝑦
𝜎𝑧𝑧−𝜎𝑖𝑠𝑜
                                                         (2.9) 
Where 𝜎𝑖𝑠𝑜 is the isotropic chemical shielding, Δ is the chemical shielding anisotropy, 
and η is the chemical shielding asymmetry. The resonance frequency of a nucleus due 
to the chemical shielding interaction is called the chemical shift frequency, ωcs: 
𝜔𝑐𝑠(𝜃, 𝜙) = −𝜔0𝜎𝑖𝑠𝑜 −
1
2
𝜔0Δ(3𝑐𝑜𝑠
2𝜃 − 1 + 𝜂𝑠𝑖𝑛2𝜃𝑐𝑜𝑠2𝜙)            (2.10) 
Where the first term is the isotropic contribution, and the second term has the 
orientational dependence between the static field and the shielding tensor PAF in polar 
angles. 
2.1.3 Dipole-dipole coupling 
The magnetic moment of nuclear spins creates their own local magnetic field. The 
interaction between the spins through space is known as dipole-dipole, or dipolar 
coupling. The strength of the interaction depends on the orientation of the spins relative 
to the external magnetic field, and the internuclear distance, and the interaction 
Hamiltonian can be written as: 
𝑯𝑫 = −2?̂? ⋅ 𝑫 ⋅ ?̂? ,                                                        (2.11) 
where ?̂? and ?̂? are the nuclear spin operators, and D is the dipole-coupling tensor, which 
describes how the magnetic field due to spin S is felt by spin I. The dipolar coupling 
tensor is always axially symmetric, and similar to the chemical shielding tensor, this 
dipole-coupling tensor D can be represented in a PAF, and is coincident with the I – S 
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internuclear vector. The orientation dependence between the PAF and B0 is (3cos2 θ − 
1), where again θ is the angle between the zPAF-axis and B0. 
The principal values of the dipolar coupling tensor are −
𝐷𝐼𝑆
2
, −
𝐷𝐼𝑆
2
, 𝐷𝐼𝑆, where 𝐷𝐼𝑆 is 
the dipolar coupling constant, which can be expressed as: 
𝐷𝐼𝑆 = (
𝜇0
4𝜋
)
𝛾𝐼𝛾𝑆ℏ
𝑟𝐼𝑆
3                                                         (2.12) 
Where 𝜇0 is the permeability of free space, ℏ is the Planck constant, 𝛾𝐼 and 𝛾𝑆 are the 
gyromagnetic ratios of spins I and S respectively, and 𝑟𝐼𝑆 is the internuclear distance 
between the two spins. 
The Hamiltonian for the dipolar coupling interaction can be expressed as: 
𝐻𝐷 = −𝐷𝐼𝑆(3𝑐𝑜𝑠
2𝜃 − 1) [?̂?𝐳?̂?𝐳 −
1
2
(?̂?𝐱?̂?𝐱 + ?̂?𝐲?̂?𝐲)]                  (2.13) 
Where θ is the angle between the zPAF-axis and B0, and ?̂?𝐳, ?̂?𝐲 and ?̂?𝐱 are the operator for 
the z, y, and x-component of the I spin (similarly for S).  
Homonuclear dipole coupling is caused by interaction between nuclei of the same type 
(I = S). The second term in Equation 2.13 contains the transverse components of the 
spin operator, and does not commute with the first term. This interaction introduces 
time dependence of the spin state, which leads to significant broadening towards a 
Gaussian resonance lineshape.  
Heteronuclear dipole coupling is caused by interaction between nuclei of different types 
(I ≠ S). The difference in the Larmor frequency of the different nuclei causes the second 
term in Equation 2.13 negligible, and hence the heteronuclear dipolar coupling and be 
treated as a frequency offsets: 
𝜔𝐷
𝐼𝑆(𝜃) = 𝐷𝐼𝑆(3𝑐𝑜𝑠
2𝜃 − 1)                                           (2.14) 
As dipolar coupling is related to the internuclear distance, study of the interaction can 
provide information about geometry and conformation of the molecule. Homonuclear 
coupling can be used for two-dimensional experiments such as double quantum – single 
quantum correlation experiment which can provide information on internuclear 
connectivity within molecules. Heteronuclear coupling can be measured in experiments 
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such as rotational-echo double resonance (REDOR), which is useful in this project to 
study the organic-mineral interface. 
2.1.4 Quadrupolar coupling 
Nuclei that have a spin quantum number greater than 
1
2
 are quadrupolar, and will be 
effected by so-called quadrupole interactions. The Hamiltonian that describes the 
interaction are: 
𝑯𝑸 =
𝑒𝑄
2𝐼(2𝐼−1)ℏ
𝐈 ∙ e𝐪 ∙ 𝐈                                     (2.15) 
where Q is the nuclear electric quadrupole moment, which is an intrinsic property of 
nuclei, eq is the electric-field gradient (EFG), generated by the surrounding 
environment, and I is the nuclear spin vector.  
The EFG is a second-rank tensor, where a principal axis frame exists in which eq is 
diagonal with corresponding principal values (qxx, qyy, qzz). Two important quadrupole 
coupling parameters are derived from these values: 
𝐶𝑄 =
𝑒2𝑄𝑞𝑧𝑧
ℎ
                                                 (2.16) 
𝜂𝑄 =
𝑞𝑥𝑥−𝑞𝑦𝑦
𝑞𝑧𝑧
                                              (2.17) 
where CQ is the quadrupole coupling constant in Hz, which indicates the magnitude of 
the interaction, and ηQ is the asymmetry parameter, which indicates the deviation of the 
EFG from axial symmetry. 
The effect of the quadrupolar interactions can be treated as a weak perturbation of the 
Zeeman interaction (as long as the first-order quadrupole splitting, 𝜔𝑄
1 , is less than 10% 
of the magnitude of the Zeeman interaction) , and only the first two perturbation terms 
are considered, i.e. 
𝑯𝑸 = 𝑯𝑸
𝟏 + 𝑯𝑸
𝟐                                             (2.18) 
The effect of the first term, or the first-order interaction, 𝑯𝑸
𝟏 , is independent of the 
external field strength. It shifts the energy level after Zeeman splitting by an amount of 
𝜔𝑄
1 : 
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𝜔𝑄
1 = 𝜔𝑄
𝑃𝐴𝐹 1
2
(3𝑐𝑜𝑠2𝜃 − 1 + 𝜂𝑄𝑠𝑖𝑛
2𝜃𝑐𝑜𝑠2𝜙)                    (2.19) 
where 𝜔𝑄
𝑃𝐴𝐹 =
3𝐶𝑞
4𝐼(2𝐼−1)
, and θ and ϕ are the polar coordinates for the orientation of the 
laboratory frame relative to the EFG PAF. This cause a single spectral line at ω0 split 
into central line and satellite lines at ω0  and ±2ωQ  away from the central line 
respectively. The orientation dependence of 𝑯𝑸
𝟏  is the same as the chemical shielding 
and the dipolar coupling interaction. 
The effect of the second term, or the second-order interaction, 𝑯𝑸
𝟐 , is inversely 
proportional to the external field, hence using a high-field magnet can significantly 
decrease the effect of the second-order interaction. The effect of 𝑯𝑸
𝟐  is to shift the 
energy levels further, causing an additional, much smaller, shift on top of the effect due 
to 𝑯𝑸
𝟏 . The central line is also shifted, and broadened due to the second-order 
quadrupole splitting, 𝜔𝑄
2 : 
𝜔𝑄
2 ∝
(𝜔𝑄
𝑃𝐴𝐹)2
𝜔0
[𝐴 + 𝐵𝑸𝟐(𝜽, 𝝓) + 𝐶𝑸𝟒(𝜽, 𝝓)]                  (2.20) 
where A, B and C are constant, and 𝑸𝟐(𝜽, 𝝓) and 𝑸𝟒(𝜽, 𝝓) are the second- and fourth-
rank tensors respectively, describing the anisotropy.  
The quadrupolar coupling makes spectra complicated and difficult to analyse. The first-
order interaction can easily be averaged by magic angle spinning (MAS), which will be 
explained later. The orientation dependence of  𝑯𝑸
𝟐  is much more complex due to the 
fourth-rank orientation dependency, so that even under MAS there is still line 
broadening and a shift of the central-line transition due to 𝑯𝑸
𝟐 . Therefore, other methods 
are required to remove the effect of 𝑯𝑸
𝟐 .  
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2.2 Experimental techniques 
2.2.1 Magic-angle spinning (MAS) 
Chemical shielding and dipolar coupling are molecular-orientational dependent, and 
this dependence is described as anisotropy. In the solution state, fast tumbling of 
molecules averages out the orientation dependence on the NMR timescale, and removes 
the effect of anisotropy. However in the solid state, molecules are fixed in their 
orientations, and each orientation produces a different spectral frequency. As a result, 
the NMR spectra of solid samples take the form of broad lines called powder patterns. 
The analysis of powder patterns can provide useful information such as electronic 
structures, but as the number of inequivalent nuclear sites increases, the overlap of their 
associated powder patterns makes the spectrum impossible to analyse. Therefore it is 
necessary to remove anisotropic effects in ssNMR in order to achieve high resolution 
spectra. 
Magic-angle spinning (MAS) is widely used in ssNMR to remove the effect of chemical 
shift anisotropy and heteronuclear dipolar coupling. In the MAS experiment, the sample 
is placed in a cylindrical rotor, which is then spun rapidly around its long axis with this 
spinning axis orientated at an angle, θR, to the external magnetic field (Figure 2.1). The 
average orientation between external magnetic field and the principal axis frames of the 
nuclear interaction tensors in the sample under spinning can be described as: 
〈3𝑐𝑜𝑠2𝜃 − 1〉 =
1
2
(3𝑐𝑜𝑠2𝜃𝑅 − 1)(3𝑐𝑜𝑠
2𝛽 − 1)                          (2.21) 
where θ is the angle between the external magnetic field and the principal z-axis of the 
interaction tensor of the nucleus, and β is the angle between the principal z-axis of the 
interaction tensor of the nucleus and the spinning axis. Since θR is under the control of 
the experimenter, if the value of 54.74º has chosen, then (3cos2𝜃𝑅 − 1) = 0, and so 
the average 〈3cos2𝜃 − 1〉 is also 0. Therefore, by rapid spinning of samples in this 
configuration, the effect of anisotropic interactions from chemical shielding and dipolar 
coupling are averaged to zero, and the angle θR = 54.74º is called the magic angle. When 
a rotor spins at the magic angle, it is effectively rotating through the x, y and z axes one 
after another, so the anisotropy due to orientation has been averaged.      
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Figure 2.1. Schematic setup for magic-angle spinning. The sample is physically spin at 
the magic angle θR = 54.74º with respect to the static magnetic field B0, average the 
effect of chemical shift anisotropy and dipolar coupling, as long as the spinning rate 
ωr is much faster than the magnitude of the interaction. 
The rate of sample spinning determines the effectiveness of MAS. Generally, the 
sample needs to be rotated at a frequency three or four times greater than the line-width 
of the powder pattern caused by the anisotropic interactions in frequency units for the 
powder pattern to “collapse” into a single peak. At relatively low spin rate, spinning 
sidebands are produced as sharp lines separated by the spinning frequency of the sample.  
For strong homonuclear dipolar coupling (e.g. 1H-1H, line-width ~ 50 kHz), the spin 
rate required to remove the spinning sidebands is unachievably high, and the 
homonuclear dipolar coupling also broadens the line-width of sidebands. 
For heteronuclear dipolar coupling between 13C and 1H, which is in a homonuclear 
dipolar-coupled network, MAS alone is not sufficient to remove all heteronuclear 
dipolar coupling. This is because for bonded 13C-1H pairs the spin rate required to 
remove the dipolar coupling is about 100 kHz, also unachievable currently. Usually a 
1H decoupling pulse sequence is used together with MAS to achieve dipolar decoupling. 
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The decoupling pulse works by rapidly flipping the nuclear spin of 1H nuclei, so on the 
NMR timescale, 13C nucleus only “see” what is effectively the average of the proton 
spin, i.e. zero, hence removing the residual dipolar coupling not removed by MAS. 
 
2.2.2 Decoupling 
The decoupling sequences used to remove the heteronuclear dipolar coupling are the 
TPPM (Two Pulse Phase Modulation) and SPINAL-64 (small phase incremental 
alternation with 64 steps). The TPPM pulse sequence consists of a series of two pulses 
with near π flip angle and alternating phases. The SPINAL-64 can be thought as the 
supercycle of TPPM pulse. It consists of 32 TPPM-like cycles (so 64 pulses per 
supercycle, as name suggested), with different phase increments. Both techniques have 
similar efficiency, and have superior in performance depending on the overall pulse 
sequence. 
 
Figure 2.2. The TPPM and SPINAL-64 decoupling scheme. The flipping angle of the 
pulse,θP, the phase φ, and the phase increments, α and β can be optimised to achieve 
best performance. The unit ?̅? has same pulse angle but opposite phase as the unit a. 
The homonuclear decoupling technique used to remove the broadening effects of strong 
1H-1H dipolar interactions is the frequency-switched Lee-Goldburg (FSLG) 
decoupling.110 This works by applying an RF field after the initial magnetisation of 1H 
is moved to the transverse plane (π/2 pulse). When this RF field satisfies the Lee-
Goldburg condition: 
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∆𝐿𝐺 = ±
√2
2
𝜔1                                                      (2.22) 
where ΔLG is the frequency of the RF field, and ω1 is the magnitude of the decoupling 
field, it produces an effective field that makes 1H magnetisation precession at the magic 
angle in the rotating frame. The precession at such angle averages out the homonuclear 
dipolar coupling interaction. The magnetisation is then spin-locked by a series of 2π 
pulses, where the length of these pulses determines the t1 delay of the experiment. The 
frequency and the phase of these 2π pulses are switched after successive periods 𝜏 =
√
2
3
(
2𝜋
𝜔1
), which corresponds to a complete 2π rotation in the magic angle axis. Such 
rapid frequency switching improves the efficiency of the decoupling. The technique is 
used for the HETCOR experiment described in Section 2.2.8. 
 
2.2.3 Double rotation (DOR) 
In this study, the Double Rotation (DOR) experiment is employed to remove the line-
broadening effect due to the second-order interaction of the quadrupolar coupling. As 
the second-order isotropic quadrupole shift is field dependent, so are the signals 
measured with DOR.  
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Figure 2.3. Scheme of DOR rotor. The outer rotor is spinning at an angle θout = 54.7º 
to the external magnetic field B0 and the inner rotor is spinning at the angle θin = 30.6º 
to the axis of the outer rotor (or 24.1º to the external field). 
The second-rank tensor has the same orientation dependence as CSA and dipolar 
coupling, which can be averaged by MAS, but the fourth-rank tensor has the orientation 
dependence of 𝑸𝟒 ∝ (35𝑐𝑜𝑠4𝛽𝑅 − 30𝑐𝑜𝑠
2𝛽𝑅 + 3), which require rotating the sample 
at 30.6º or 70.1º to average out the fourth-rank tensor. 
The DOR experiment requires a special rotor. The sample is placed in a small inner 
rotor that can spin within a larger outer rotor, which is also rotating at a different rate. 
The outer rotor is spin at the magic angle θout = 54.7º to the external magnetic field, and 
the inner rotor is spun at the angle θin = 30.6º (one of the ‘magic angles’ of the fourth 
rank tensor) to the magic angle axis (or 24.1º to the external field). In order to have an 
efficient averaging, the inner rotor needs to rotate at least five times faster than the outer 
rotor. 
The complexity of the special rotor limits the spinning rate the experiment can achieve, 
which is much lower than the normal MAS experiment, leading to spinning sidebands. 
Information about anisotropies can be extracted from well resolved sidebands, but in 
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many cases they can complicate the interpretation of the DOR spectra. The sidebands 
can be suppressed by an outer rotor synchronised pulse, where the excitation pulse is 
applied when the inner rotor is at two positions - in plane with the magnetic field, and 
the axis of the outer rotor (ie. γ = 0º and 180º in Figure 2.3). The spectra generated this 
way will have oppositely sense odd numbered sidebands, and the sum of the spectra 
will only show even numbered sidebands, effectively doubling the rotation speed. 
2.2.4 Direct-polarisation (DP) 
The most straightforward experiment in ssNMR is the direct-polarisation (DP) 
experiment. As discussed in Section 2.1.1, when an external magnetic field is applied, 
a bulk magnetisation results, which precesses around the magnetic field at the Larmor 
frequency (𝜔0). The axis of the precession, i.e. the direction of the applied magnetic 
field, is generally defined as the z-axis, the plane perpendicular to it is the transverse 
plane, or the x-y plane. When a radio frequency (RF) pulse which is resonant with the 
Larmor frequency is applied in the x-direction, the bulk magnetisation is rotated into 
the transverse plane. The simplest way of understanding the magnetisation rotation is 
by considering the system in a reference frame which rotates at frequency ω0. In this 
rotating frame, the effective magnetic field, Beff, is zero (in general, ω = γB, so in the 
rotating frame, ω = 0, so Beff = 0), so the on-resonance RF pulse in the x-direction acts 
as the only magnetic field in the rotating frame, and causes the bulk magnetisation in 
the rotating frame to rotate towards the transverse plane. A π/2 pulse is an RF pulse of 
a length which results in the nuclear magnetisation rotating to the transverse plane. The 
magnetisation is then allowed to precess in the transverse plane resulting in a free 
induction decay (FID), recorded as induced current in a coil surrounding the sample. 
Finally, Fourier transform of the FID signal gives the NMR spectrum. 
The pulse sequence of the DP experiment is shown in Figure 2.4. It consists of a π/2 
(90º) RF pulse on the X-channel (corresponding to the observed nucleus) to achieve 
transverse magnetisation, followed by a signal acquisition period. If there is strong 
heteronuclear dipolar coupling due to a coupled 1H network a decoupling pulse 
sequence is applied during signal acquisition to remove this.  
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Figure 2.4. Pulse sequence for direct-polarisation experiment. A π/2 pulse on the X-
channel followed by FID acquisition, and decoupling on the 1H-channel. 
The DP experiment is not routinely used in ssNMR of organic materials because most 
of the common nuclei (e.g. 13C, 15N, 31P, etc.) have long T1 relaxation times (time taken 
to build up or return to equilibrium longitudinal magnetisation). For quantitative 
analysis of the spectrum, recycling time (i.e. the time delay between each scan) needs 
to be at least five times the T1 value. Especially for low abundance nuclei such as 
13C, 
where the recycle time is in the order of 1-10 minutes, it would take a very long time to 
acquire a spectrum with satisfactory signal-to-noise. Fortunately, the only quantitative 
analysis required in this work is for 31P, which is 100% abundant, so although a recycle 
time of 10 minutes is required, a few scans (four) is sufficient to produce a satisfactory 
spectrum. 
2.2.5 Cross-polarisation 
Cross-polarisation (CP) is widely used in ssNMR, including as the initial preparation 
step in many different experiments. The technique transfers proton magnetisation to the 
observed nuclei, mediated by the mutual dipolar coupling interaction. The experiment 
increases the signal-to-noise ratio (S/N) up to a theoretical maximum of γH/γX, where 
X refers to the observed nucleus. It also usually reduces recycling time to few seconds, 
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as the protons have very short relaxation times due to the strong dipolar interactions 
between them. The CP experiment only requires that the 1H nuclear magnetisation 
relaxes between scans, independent of the relaxation of the observed nuclei. Therefore 
the CP experiment provides higher S/N in shorter time compared to DP. 
 
Figure 2.5. Pulse sequence for the cross-polarisation experiment. A π/2 (90º) pulse on 
the 1H channel is followed by a contact pulse, where the Hartmann-Hahn matching 
condition is achieved, and 1H magnetisation is transferred to the X spin. FID 
acquisition on X channel is accompanied by a decoupling pulse on the 1H channel. 
As shown in Figure 2.5, the CP pulse sequence begins with a 1H π/2 pulse, followed by 
“contact” pulses, applied to both 1H and X spins. By considering a double rotating 
frame, where 1H spins are in a frame rotating at the nutation frequency of the 1H RF 
contact pulse and X spins are in a frame rotating at the nutation frequency of the X RF 
contact pulse, the contact pulse creates Hartmann-Hahn matching, as well as a spin-
lock field so that the 1H magnetisation (and X magnetisation after the magnetisation 
transfer) is effectively “locked” in the transverse plane.  At the heart of the CP 
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experiment, is the Hartmann-Hahn matching condition: 
𝛾𝐻𝐵1( 𝐻
1 ) = 𝛾𝑋𝐵1(𝑋) ,                                                 (2.23) 
where B1(
1H) and B1(X) are the magnetic fields due to the contact pulses, experienced 
by 1H and X spins respectively in the double rotating frame. When the Hartmann-Hahn 
condition is achieved, the energy gap between the 1H spin states and the X spin states 
in the double rotating frame is equal. In order to conserve energy and angular 
momentum, any reduction of the spin locked 1H magnetisation in the doubly rotating 
frame is countered by an increase in the spin locked X magnetisation. Since this transfer 
in magnetisation is in the transverse plane, an FID of X can be recorded immediately 
after the cross-polarisation step. 
Since CP is mediated by the dipolar coupling interaction between 1H and X, anything 
that disrupts the interaction also disrupts CP. So for MAS, which averages dipolar 
coupling to zero, if the sample is rotated at very fast rates so that the dipolar coupling 
is being averaged rapidly compared to the CP transfer rate, it can reduce magnetisation 
transfer dramatically. MAS also affects the Hartmann-Hahn matching condition, as the 
MAS causes the Hartmann-Hahn matching to display modulation due to sideband 
match conditions: 
𝜔1
𝐻 − 𝜔1
𝑋 = ±𝑛𝜔𝑅  (n = 1 or 2),                                      (2.24) 
where ω1 is the spin lock nutation frequency for 1H and X nuclei, and ωR is the spin 
rate. In order to increase CP efficiency under MAS, a ramped amplitude CP pulse is 
used on one of the nuclei (normally on the 1H spin) as shown in Figure 2.5. The 
amplitude of the ramped spin lock pulse is increased steadily during the contact period 
and usually covers a range of 2-3 ωR in terms of nutation frequency, centred at the 
normal 1H-1H match condition. 
2.2.6 Rotational-echo double resonance (REDOR) 
As discussed in the Section 2.1.3, the strength of dipolar coupling is related to the 
internuclear distance, r (actually, it is 1/r3), therefore the dipolar coupling can be used 
as a probe of this distance. However, as most ssNMR experiments need to be carried 
out under MAS to remove the complications due to chemical shift anisotropy, the 
dipolar coupling is averaged as well. Experiments have been developed to re-introduce 
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heteronuclear dipolar coupling, and Rotational-Echo DOuble Resonance (REDOR) 
experiment is one example.111  
 
Figure 2.6. REDOR experiment pulse sequence. Magnetisation of I spins is achieved 
by cross-polarisation. A spin-echo sequence for the I spins is introduced to refocus 
chemical shift dephasing before FID acquisition. Rotor-synchronised π pulses are 
applied on the S spins, with decoupling implemented throughout the dephasing period 
(period after CP and before acquisition). 
The pulse sequence of the REDOR experiment is shown in Figure 2.6, where I and S 
have to be different isotopes. The I-spin magnetisation (observed) is transferred into the 
transverse plane, usually achieved by CP, followed by a spin-echo pulse sequence (τ-
π-τ, where τ is a delay time before and after the π pulse. For the REDOR experiment, 
2τ is referred to as the dephasing time) before acquisition. The spin-echo sequence is 
used here to refocus I-spin dephasing resulting from chemical shift offset. The S-spin 
is pulsed with a series of rotor-synchronised π pulses, which prevent averaging of 
dipolar coupling due to MAS. These π pulses are applied at every half rotor period, 
because the effect of MAS averaging is symmetric about these time points, i.e. 
evolution of the transverse magnetisation under the effect of dipolar coupling in the 
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first half rotor period is cancelled in the second half. The π pulse on the S spin flips the 
sign of the interaction, therefore instead of MAS cancelling out dipolar evolution, 
pulsing at every half rotor period sums the effect of dipolar coupling to produce the 
maximum dipolar dephasing which results in a signal intensity reduction at the end of 
the dephasing period. 
The REDOR experiment is usually performed in two stages: a reference experiment in 
which no REDOR π pulses are applied, and a dephasing experiment, in which they are. 
The difference in intensity of the spectra arising from the two experiments is related to 
the strength of the I-S dipolar coupling, and the difference in intensity increases as 
dephasing time increases. A graph of intensity difference against dephasing time allows 
the I-S dipolar coupling constant to be determined for a simple two spin system, and 
hence the internuclear I-S distance. For this project, where the 13C {31P} REDOR 
experiment is used, 13C corresponds the observed I spin, and 31P corresponds to the S 
spin. 
2.2.7 2D NMR experiments 
Two-dimensional (2D) techniques introduce a second frequency axis to the NMR 
experiment. 2D NMR spectra can contain far more information than conventional 1D 
spectra. They can resolve signals which overlap in 1D spectra, and can elucidate spatial 
proximities within a molecule or material. They can also be used to follow the 
internuclear distance-dependent evolution of multiple-quantum coherence from which 
spatial proximities can also be inferred. In spite of this 2D NMR does have certain 
disadvantages. In general, it takes much longer to record a 2D spectrum, and for those 
nuclei with low natural abundance such as 13C (1%), isotope enrichment is often 
required, hence special sample preparation is needed. Also, the high information 
content of spectra can make them difficult to analyse. 
2D NMR experiments are generally have four different stages: 
𝑝𝑟𝑒𝑝𝑎𝑟𝑎𝑡𝑖𝑜𝑛 → 𝑒𝑣𝑜𝑙𝑢𝑡𝑖𝑜𝑛 (𝑡1) → 𝑚𝑖𝑥𝑖𝑛𝑔 → 𝑑𝑒𝑡𝑒𝑐𝑡𝑖𝑜𝑛 (𝑡2) 
In the preparation stage, the equilibrium spin system is excited by RF pulses (such as 
the CP sequence) to create initial magnetisation on the I spin. The magnetisation is then 
allowed to evolve for time t1 during the evolution stage, under the influences of 
chemical shift, dipolar coupling etc. During the mixing stage, more RF pulses are 
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applied in order to generate observable transverse magnetisation on S spins (I and S can 
be the same or different NMR isotopes). This observable magnetisation is recorded and 
usually labelled as t2.  
Each cycle of the above four stages is effectively a 1D experiment. The 2D spectrum is 
obtained by running a series of these 1D experiments, where the only variation 
introduced is a systematic increment of t1 by a fixed amount, τ. Then Fourier 
transformations are applied to both t1 and t2 axes, so the two-dimensional array of FIDs 
is converted from the time- to the frequency-domain. The vertical axis (t1) is 
conventionally known as the F1 dimension, which effectively contains 1D subspectra 
of spin I, and the horizontal axis the F2 dimension, which contains 1D subspectra of 
spin S. A signal at (ω1, ω2) represents a magnetisation transfer interaction between the 
spin I with frequency ω1 and spin S with frequency ω2 during the mixing stage.  
2.2.8 Heteronuclear correlation (HETCOR)  
The heteronuclear correlation (HETCOR) experiment is an important 2D NMR tool for 
signal assignment and resolution enhancement. The variant used in this study is the 
frequency-switched Lee-Goldburg (FSLG) 1H homonuclear decoupled 1H-X HETCOR 
(see Section 2.2.2 for the detail of homonuclear decoupling). The pulse programme is 
shown in Figure 2.7. 
The experiment works by introducing a t1 spin evolution period into a 
1H-X CP 
experiment, between the 1H /2 preparation pulse, and the contact pulses. During this 
t1 period, the dipolar coupling interactions between 
1H and X evolve, while the 1H-1H 
homonuclear dipolar coupling is suppressed by the FSLG pulse sequence. So the 
resulting 2D spectrum yields spatial information by identifying close proximities 
between 1H and X nuclei. 
 
 
Chapter 2: Solid-State Nuclear Magnetic Resonance Spectroscopy 
37 
 
 
Figure 2.7. Pulse sequence for FSLG HETCOR. The 1H magnetisation is flipped to the 
magic angle, and maintained by a series of 2π pulses at alternating frequency. During 
this period, the 1H-1H dipolar coupling interactions are supressed, while the 1H-X 
dipolar interactions are allowed to evolve. Then transverse magnetisation of 1H is 
prepared, and transferred to the X spin by CP for detection with 1H decoupling. 
2.2.9 Single quantum – double quantum correlation, using 
permutationally-offset stabilised C7 (POST-C7) 
The single quantum – double quantum (SQ – DQ) experiment, which recouples the 
homonuclear dipolar coupling interactions and hence generates correlations between 
directly attached X-atoms. The POST-C7 pulse sequence was developed in 1998, as a 
modification on the existing C7 sequence, which improves the shortcomings caused by 
RF inhomogeneity and isotropic resonance offsets, and increase the double quantum 
filtering efficiency (which provides better signal-to noise ratio). 
The pulse sequence of POST-C7112 is shown in Figure 2.8. After the initial CP stage, 
the magnetisation is transferred to the spin X. Then a train of rotor synchronised pulses 
(block a) is applied to the system to excite double-quantum (DQ) coherences, which is 
the coupling between |↑↑⟩ and |↓↓⟩ states. This excitation pulse is constructed by 7 𝐶𝜑
𝑖  
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pulse elements, where i is the ith element in the pulse train, and φ is the phase of the 
pulse. Each 𝐶𝜑
𝑖  element has duration of 2Tr/7, where Tr is the length of rotor period, 
and the phase is incremented by 2π/7. This DQ state is then allowed to evolve for time 
t1, and then a train of rotor synchronised reconversion pulses (block b) with an 
additional phase shift of Φ = {
𝜋
2
, 𝜋,
3𝜋
2
, 0} for each repeat scan is applied to reconvert 
the DQ coherence to observable SQ magnetisation. Due to this 4-step phase cycling 
process, the number of scans for POST-C7 is always a multiple of four. The signal is 
then detected in time t2. 
 
 
Figure 2.8. The POST-C7 pulse sequence. After initial CP step, the double quantum 
coherences are generated by a series of 7-step cycle pulses (block a). Then the double 
quantum coherence are converted to single quantum coherence via a second series of 
7-step cycle pulses (block b). 
The excitation of the DQ coherence is mediated by the through-space dipolar coupling 
tensor. Therefore by recording a number of POST-C7 spectra in which the length of the 
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excitation/reconversion step is systematically incremented, near-neighbour atoms can 
be identified and in favourable cases internuclear distances determined.  
2.3 Summary 
The chapter has presented a brief theoretical introduction to the nuclear spin 
interactions on which the solid-state NMR experiments used in this project are based. 
These techniques have been used to characterise and investigate the structures of OCP-
metabolite composites, and assist the formulation of molecular models of these 
composite materials. 
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Chapter 3:                       
Characterisation of Octacalcium 
Phosphate – metabolite Composites 
 
Bone is a complex material. The network of organic matrix and the mineral intertwined 
together are difficult to separate from each other without disruption of their respective 
structures. Deproteination processes and other experimental preparation processes such 
as fixation for TEM can destroy the delicate biological apatite mineral structure, for 
instance through dehydration, causing the collapse of the platelet mineral structure into 
more aggregated forms.113,114 Moreover, bone samples are subject to variation due to 
the individual organism and anatomical site. If the hypothesis that small organic 
metabolites are incorporated into bone mineral is correct, then each individual bone 
sample may have different metabolite compositions in the mineral, and contribute to 
variations of bulk properties. Therefore, in order to understand how metabolites may 
affect mineral structure and physical properties, model compounds are useful for 
structural characterisation as a function of metabolite incorporation, as model 
compounds can be relatively easy to synthesise in large quantities, with control of their 
homogeneity with respect to composition and quality.  
OCP-succinate (OCP-SUC), first synthesized in 1983,115 has been studied by many 
researchers, partly due to its facile preparation and highly crystalline nature, mainly by 
powder XRD and FTIR methods.116–119 OCPs incorporating other organic acids have 
also been synthesized and characterised by Markovic et al.120,121 with XRD, IR and 
Raman spectroscopy. Though these techniques were able to confirm the presence of the 
organic acid anions in the compounds, they cannot provide information on the structural 
arrangement of the organic acids within the compound. The structure of OCP-SUC has 
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been proposed with the aid of crystallography data from OCP, however no detailed 
experimental data is available to support the model except the unit cell dimensions 
obtained from XRD.121 In 2010, Tsai et al.116 used solid-state NMR spectroscopy to 
investigate the phosphorus environments of OCP-SUC, and suggested the substitution 
sites for the succinates in the compound by comparison with NMR data for OCP. 
However, a later study by Davies et al.122 using a combination of solid-state NMR 
spectroscopy and DFT calculations, suggested that the initial assignment of the OCP 
31P NMR spectrum used by Tsai was incorrect, raising doubts about the NMR 
assignments for OCP-SUC and hence the proposed structure. 
OCP-citrate (OCP-CIT) has been proposed as a model for the hydrated layers between 
bone mineral platelets.11 In this model, citrate anions coordinate to calcium ions and 
bridge the hydrated layer between apatitic sheets. Many different metabolites can 
coordinate to calcium, and it is possible other metabolites are also involved and trapped 
within the mineral structure during mineralisation.7–9,12,13 Due to their difference in size 
and affinity to calcium, and the protonation state of the acids, one may expect 
incorporation of different metabolites will yield minerals with different physical and 
chemical properties. Therefore, the metabolite composition of bone is potentially highly 
relevant to understanding dysfunctional bone.  
As a first step to understanding the effect of different metabolites within the mineral, 
different OCP-metabolite composites will be synthesized as model compounds, and 
characterised by, predominantly, solid-state NMR spectroscopy to determine and 
compare their structures. 
3.1 Experimental 
3.1.1 Synthesis 
There are two synthetic routes to prepare OCP-metabolite composites:  
 Route 1: hydrolysis of α-TCP in the presence of the target metabolite (10 days);  
 Route 2: mixing of calcium carbonate, orthophosphoric acid and the target 
metabolite (6 hrs).  
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Various synthetic conditions were explored during the work. The Route 2 is 
considerably faster than the first, and much more robust to produce wanted products 
when scaled-up and scaled-up down synthesis was performed for different purposes. 
However, Route 2 did not produce any product with citrate as the target organic 
molecule for incorporation. This may be due to the high affinity of citrate for calcium, 
with the calcium citrate being more stable than the OCP-CIT complex. The α-TCP 
method yielded product after 24 hrs, however NMR showed a fair amount of unreacted 
α-TCP still present, therefore, 10 days were used to ensure the reaction went to 
completion. 
The α-TCP method (Route 1) is much more sensitive to the pH of the reaction. Reaction 
with initial pH below 6.0 has very slow rate (lots of unreacted α-TCP at the end). Also, 
inhomogeneous temperature will affect the phase of the product. It is found that 
hydroxyapatite was formed at the bottom of the baker where it is in contact with the 
hot-plate if no water bath was used, due to high local temperature. 
Different ratio of citrate to lactate/formate was used to synthesize double metabolite 
compounds (OCP-CF and OCP-CL).  There is only OCP-CIT formed when the 
concentration of citrate was more than twice of the concentration of formate/lactate. 
The best result was found with 1:2 ratio of citrate to formate/lactate, and no successful 
synthesis was achieved with other ratio combination to synthesis OCP-CF, while OCP-
CL was produced with 1:3 and 1:4 ratio of citrate to lactate. 
Most reagents were purchased from Sigma-Aldrich and used without any further 
treatment. U-13C4 labelled succinic acid (100% labelling) was purchased from 
Cambridge Isotope Laboratories, and 43Ca labelled calcium carbonate (60% labelling) 
was provided by Danielle Laurencin, University of Montpellier.  
The elemental analysis was performed by the Microanalysis service, Department of 
Chemistry, University of Cambridge. The CHN elements was measured with Exeter 
Analytical CE440 elemental analyser, samples were combusted at 975 °C in oxygen. 
The calcium and phosphorus were measured with Thermo Scientific 7400 ICP-OES, at 
396.84 nm and 178.28 nm respectively. The SEM images was taken at Multi-imaging 
Centre, University of Cambridge. 
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Route 1: 
A solution of the metabolite in water (100 ml) was maintained at 37 °C, and the pH was 
adjusted to 5.50 by dropwise addition of NaOH. α-TCP (1.60 g, 5.3 mmol, fine powder) 
was then added and the pH was adjusted to 6.50 by dropwise addition of NaOH. The 
suspension was stirred at 300 rpm for 10 days, and the solid was collected by gravity 
filtration and dried in air. 
The following compounds were synthesized via Route 1: 
 OCP-CIT (citric acid 5.22 g, 27.6 mmol) collected as white powder (1.24 g). 
 OCP-LAC (sodium L-lactate 2.8 g, 25 mmol), collected as white powder (1.01 
g). 
 OCP-FOR (sodium formate 1.7 g, 25 mmol) collected as white powder (0.88 g). 
 OCP-CF (citric acid 1.32 g, 6.9 mmol; sodium formate 0.85 g, 12.5 mmol) 
collected as white powder (0.68 g). 
 OCP-CL (citric acid 1.32 g, 6.9 mmol; sodium L-lactate 1.4 g, 12.5 mmol), 
collected as white powder (0.62 g) 
Route 2: 
The metabolite was dissolved in water (200 ml) and the pH was adjusted to 5.5 by 
dropwise addition of NaOH. The solution was heated to 60 °C with stirring, and calcium 
carbonate (1.604 g, 16 mmol) and orthophosphoric acid (0.6 ml, 10 mmol) was added. 
The suspension was left to stir for 6 hrs, and the solid was collected by gravity filtration 
and dried in air.  
The following compounds were synthesized via Route 2: 
 OCP (no metabolite was used) collected as white powder (1.14 g, 0.58 mmol). 
 43Ca-enriched OCP (no metabolite was used, and no pH adjustment was 
required. Water 30 ml; 43CaCO3 40 mg, 0.388 mmol; orthophosphoric acid 20 
µl, 0.384 mmol) collected as white powder (32 mg, 0.068 mmol). 
 OCP-SUC (2.363 g, 20 mmol) collected as white powder (1.25 g). 
 OCP-ADI (2.92 g, 20 mmol) collected as white powder (1.29 g). 
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 13C, 43Ca-enriched OCP-SUC (13C labelled succinic acid 60 mg, 0.492 mmol; 
water 30 ml; 43CaCO3 40 mg, 0.388 mmol; orthophosphoric acid 20 µl, 0.384 
mmol) collected as white powder (29.4 mg). 
3.1.2 Leaching experiment 
To identify metabolic acids present inside the bone mineral structure, a sheep bone 
sample (obtained via Dr Roger Brooks, Department of Surgery, under the appropriate 
ethical license) was dissolved in acid to leach out any organic molecules incorporated 
into the mineral. Solution-state NMR spectroscopy was used to identify the species 
released.  
Adult sheep cortical bone samples were cut into small pieces, and cryo-milled into 
powder. The bone powder was then soaked in 0.1 M of HCl to dissolve the minerals. A 
trace of sodium azide was added as bacteriostatic agent. 
The supernatant was collected and freeze dried under vacuum at different time point 
(day 1, 2, 3, 4, 7 and 16), and fresh HCl solution was added to the remaining samples. 
The remaining solids from the dried supernatant were then dissolved in D2O, and 
solution-state NMR was performed. 
3.1.3 NMR spectroscopy 
A Bruker 400 MHz Avance II spectrometer was used for solid-state 1H, 13C and 31P 
NMR measurements, at frequencies of 400.42 MHz, 100.6 MHz and 162.1 MHz 
respectively, with standard Bruker double and triple resonance MAS probes. Samples 
were packed into disposable HR-MAS inserts where necessary, and loaded into the 4 
mm zirconia rotors for magic angle spinning (MAS), at a rate of 10 kHz, unless 
otherwise stated.  
Samples were characterised using direct-polarisation (DP), cross-polarisation (CP) and 
rotational-echo double resonance (REDOR) techniques (1H 90° pulse length 2.5 μs, 31P 
90° pulse length 2.57 μs, 1H-13C CP contact time 2500 μs. 1H-31P CP contact time 10 
ms, recycle time of 600 s were used for 31P DP experiments, and 2 s for CP experiments 
or experiments which employed the CP technique. REDOR experiments used typical 
REDOR dephasing times of 2-10 ms.) 
Broadband SPINAL 64 decoupling during signal acquisition for above experiments. 
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The 1H-31P heteronuclear correlation (HETCOR) experiment was performed with 
Frequency-Switched Lee-Goldburg (FSLG) decoupling during t1 (
1H field strength 100 
kHz, 2 ms contact time, 1 s recycling time). The POST-C7 pulse sequence was used for 
the 2D SQ-DQ 31P correlation experiment (31P field strength 61 kHz, 28 composite C7 
cycles for DQ excitation and reconversion, 1 s recycling time). 
Broadband SPINAL 64 decoupling during signal acquisition for above experiments. 
13C spectra were referenced to the glycine Cα signal at 43.1 ppm relative to TMS at 0 
ppm. 31P spectra were referenced to the hydroxyapatite signal at 2.6 ppm relative to 85 
wt% H3PO4 at 0 ppm. 
1H spectra were referenced to the hydroxyapatite signal at 0 ppm 
relative to TMS at 0 ppm. 
All solid-state 43Ca NMR measurements were performed at the UK 850 MHz solid-
state NMR Facility, at frequency of 57.2 MHz, with 43Ca field strength 50 kHz, with 
Professor Christian Bonhomme and Dr Danielle Laurencin, with the assistance of Dr 
Dinu Iuga. The natural abundance 43Ca experiments were performed with a single 
channel 7 mm low gamma probe, and the labelled samples were examined with 4 mm 
low gamma double resonance probe. All samples were packed into the 7 mm or 4 mm 
zirconia rotors, and spun at 5 kHz and 12.5 kHz respectively. The DOR experiment was 
performed with a Samoson DOR probe, rotating at 1480 Hz and 6950 Hz for the outer 
and inner rotor respectively. RAPT90sel pulse sequence was used for CT enhancement. 
43Ca spectra were referenced to CaCl2 (1 M) in D2O at 0 ppm. 
The solution state 1H NMR measurements for the leaching experiment were carried out 
on a Bruker 500 MHz Avance III HD spectrometer and DCH cryoprobe, at frequency 
of 500.2 MHz (field strength 23.5 kHz) with 10% D2O solvent. A standard water 
suppression pulse sequence was used with presaturation during recycling period. 
3.1.4 DFT calculations 
The software CASTEP 7.0.1123 was used for geometry optimisation of input mineral 
crystal structures and calculation of NMR parameters for those structures. The 
programme was used on the Darwin Supercomputer of University of Cambridge High 
Performance Computing (HPC) service. An octacalcium phosphate structure was used 
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as the starting point to set up geometry input files. The Perdew-Burke-Ernzerhof (PBE) 
exchange-correlation function was used in the DFT calculations, and ultrasoft 
pseudopotentials were used to describe core electronic interactions. Plane-wave basis 
sets were used to model the electronic wavefunctions, with a cut-off kinetic energy of 
680.28 eV (50 Rydberg). A Monkhorst-Pack grid of 0.1 Å was used to sample the 
Brillouin zone, and no symmetry constraints was applied. The Tkatchenko-Scheffler 
dispersion correction scheme was used to account for van der Waals interactions. The 
NMR calculations using CASTEP gives the isotropic chemical shielding, σiso, rather 
than the isotropic chemical shift, δiso. The chemical shielding can be converted to 
chemical shifts with equation: δiso = σref − σiso, where the σref can be determined by 
either performing calculations on a reference compound with known δiso, or by fitting 
the calculated values to the experimental values. The σref = 170.9 ppm was used for the 
13C chemical shifts124, σref = 274.9 ppm were used for the 31P chemical shifts. The 43Ca 
chemical shifts was converted with equation: δiso = (1122.5 − σiso)/1.245.125 
The calculations were performed using the Darwin Supercomputer of the University of 
Cambridge High Performance Computing Service, provided by Dell Inc. using 
Strategic Research Infrastructure Funding from the Higher Education Funding Council 
for England. 
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3.2 Results and Discussion 
3.2.1 Characterisation of Octacalcium Phosphate – Succinate 
(OCP-SUC) 
The synthesis was carried out many times to cover possible composition variation. The 
13C ssNMR spectra and CHN chemical analysis a identified few different compositions, 
which have different 13C peak distributions. But the majority of the syntheses gave 
NMR spectra and CHN analysis that were very similar. The NMR spectra of typical 
OCP-SUC are characterised by two carboxylate peaks and two methylene peaks. 
The chemical analyses gave an average carbon content of 4.26 wt% (range 4.0 – 4.6 
wt%). The chemical formula for OCP-SUC deduced from the wt% of Ca, P, C and H 
for a typical of the sample is: 
Ca8(HPO4)1.08(PO4)4(succinate)0.91 · 5-6H2O 
This chemical formula is in excellent agreement with the formula proposed by 
Markovic121:  
Ca8(HPO4)1.07(PO4)4(succinate)0.93 · 6H2O 
This formula predicts two (succinate)2− species within the unit cell, and the authors 
proposed two possible models of OCP-metabolite compounds.121 Based on this 
assumption, Model I has both metabolites placed vertically across the hydration layer 
of the OCP, and Model II has one of the metabolite vertically across the hydration layer 
while the other is diagonally placed. The diagonal distance of the hydration layer in the 
OCP unit cell is around 0.98 nm, and the length of succinate is around 0.526 nm, with 
average distance for Ca-O bond is 0.25 nm between succinates and the calcium ion. 
The substitution in Model II will not yield the sizeable expansion (predicted 0.26 nm 
increase) in the a-axis dimension that has been detected experimentally. Therefore, 
Model I will be used here as a starting point to construct the structure of OCP-SUC. 
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Figure 3.1. Models proposed in the literature121 for OCP-metabolite compounds 
 
An SEM image of OCP-SUC (Figure 3.2) shows it has a highly crystalline, thin platelet 
morphology, which is in agreement with the study by Tsai et al.,116 which found that 
the crystallographic a-axis of the OCP-SUC crystals was perpendicular to the flat 
surface of the crystals. The preferential direction for crystal growth is expected to be 
similar to that of OCP, which is in the c-axis direction, stabilised by the extended 
hydrogen-bonding network in the water channel.122 
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Figure 3.2: SEM image of OCP-SUC, showing highly crystalline and platelet 
morphology. 
 
Figure 3.3. Powder XRD diffractograms of OCP (blue) and OCP-SUC (red). 
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The shift in the (100) reflection of the crystal from powder XRD is direct evidence of 
the expansion of the OCP unit cell along the a-axis to accommodate the incorporation 
of the succinate anions. The measured (100) reflection angle is 4.71° for OCP and 4.13° 
for the OCP-SUC samples synthesized here, and corresponds to 1.876 nm and 2.136 
nm respectively, which are consistent with those reported by Markovic et al.121 The 
hydration state of the sample has an effect on the d100 spacing; extended drying under 
vacuum shrinks the spacing of the OCP-SUC to 2.019 nm (not shown).  
Solid-state NMR spectroscopy was used to gain more structural information. Many 
batches of OCP-SUC were synthesised and examined with ssNMR. The typical 13C 
spectra (Figure 3.4) show a number of different peaks for the succinate molecules, but 
the 31P spectra (Figure 3.4) for these samples are very similar. The results suggested 
that the difference is due to multiple environments for the succinates in the hydrated 
layer, most likely caused by interaction with variable numbers and/or position of water 
molecules and variable orientation of the succinate molecules within the hydration layer. 
The phosphorus environments would be expected to be relatively unaffected by the 
structures in the hydrated layer.  
31P NMR spectra 
The 31P NMR spectra of OCP and OCP-SUC are shown in Figure 3.5. The sharpness 
of the peaks, and the similarity of the spectra for OCP and OCP-SUC suggested similar 
symmetry within the crystallographic unit cell. The OCP unit cell has P1 symmetry. It 
is possible to preserve such symmetry when succinate is substituted in the hydration 
layer. The sharp peaks of the 13C spectra also support the idea that succinates are 
ordered within the structure, also that there are just two signals for each of the four 
methylenes and carboxylates expected per unit cell suggests some symmetry in the unit 
cell arrangement. The sharpness and the chemical shifts of the Pa and Pb 
31P NMR peaks 
suggested that there is less proton exchange (break of hydrogen bonds in OCP), and the 
water environments are different for these two phosphates. The Pa signals are hydrated 
orthophosphates undergoing proton exchange with water, and Pb signals are hydrogen 
phosphates, also hydrogen bonded to water molecules. The change in hydrogen 
bonding between OCP and OCP-SUC can also observed in the 1H spectrum (Figure 
3.6). The 1H NMR peaks of water molecules in OCP-SUC have lower chemical shifts 
than in OCP, due to reduction in hydrogen bonding. 
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Figure 3.4. 1D ssNMR spectra for OCP-SUC resulting from different synthesis. Top: 
13C CP spectra show different environments for the carboxyl carbon (blue) and the 
methylene carbon (red). Bottom: 31P DP spectra. 
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Figure 3.5. 31P DP spectrum for OCP-SUC (blue) and OCP (black). 
 
 
Figure 3.6. 1H DP spectrum for OCP (red) and OCP-SUC (blue). The water signals for 
OCP and OCP-SUC are 5.11 ppm and 4.84 ppm respectively. The lower chemical shift 
of the water protons for OCP-SUC suggests weaker hydrogen bonding for water 
molecules in the hydration layer. 
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Figure 3.7. Deconvolution of the 31P DP spectrum of OCP-SUC. The area under the 
deconvoluted 31P peaks (except HAp) are shown 1:1:1:1:1 ratio, suggesting equal 
abundance of each site. 
2D 31P single quantum – double quantum (SQ-DQ) NMR experiments show the spatial 
proximity of the 31P nuclei in the samples. The spectrum for OCP-SUC is very similar 
to that of OCP (Figure 3.8), showing the same pattern of correlations in the 
orthophosphate region (P4/P1/P2). However, the P1 orthophosphate self-correlation 
signal, resulting from spatial proximity of P1 in neighbouring unit cell is slightly 
different for OCP and OCP-SUC. For OCP, the correlation falls as expected on the 
spectrum diagonal (y = 2x); for OCP-SUC, the correlation is slightly off-diagonal, 
suggesting slightly different P1 phosphorus environments between adjacent unit cells. 
This may be due to different succinate orientations in different unit cells, or the  
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Figure 3.8. 2D 31P SQ-DQ spectra for OCP (left) and OCP-SUC (right). The horizontal 
dotted lines (red) show the spatial proximity between phosphorus sites. Both OCP and 
OCP-SUC shown similar patterns suggest resemblance of the apatitic layer between 
the two materials. 
succinate orientation in each unit cell is not perfectly symmetric w.r.t the unit cell centre 
of symmetry, resulting in differences between the top and bottom apatitic layers within 
a unit cell, and hence two slightly different P1 phosphorus. The major difference 
between the spectra for OCP and OCP-SUC is the separation of the single P3/P5/P6 
correlation into two distinct Pa (P3) and Pb (P6) correlations. Despite this separation, all 
the correlations between P4/P1/P2 and P3/P5/P6 in OCP remained as correlations 
between P4/P1/P2 and Pa/Pb in OCP-SUC (red box). The same correlation pattern 
between the orthophosphates and hydrogen phosphates for OCP and OCP-SUC 
confirms the idea that the orthophosphates in the apatitic region are not significantly 
affected by succinate incorporation and succinate substitutes for hydrogen phosphate 
in the hydration layer, which is very likely to be the OCP P5 phosphate due to the 
disappearance of this signal.  
The 1H-31P heteronuclear correlation (HETCOR) experiment provides information on 
the distance between hydrogen and phosphorus atoms, which can be used to identify 
the phosphorus environments and their relationships to the hydration layer within the 
OCP-SUC structure. The HETCOR spectrum for OCP-SUC (Figure 3.9) shows similar 
features to that for OCP. It shows 1H-31P correlation for hydrogen phosphates, and 
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hydrated orthophosphates. The strong correlation between the hydrogens of water 
hydrogen phosphate to the Pb and Pa phosphorus confirmed that these two phosphate  
 
Figure 3.9.1H-31P HETCOR spectrum for OCP-SUC (left) and OCP (right), with 
FSLG in t1. 200 us contact time was used. 
sites are close to the hydrated layer. The 1H chemical shift (F1 dimension, y-axis) for 
water and hydrogen phosphate in OCP-SUC is less than for OCP, in agreement with 
the respective 1H spectra, and consistent with the idea that the hydrogen bonding in the 
hydrated layer of OCP-SUC is weaker than that in OCP. 
13C NMR spectra 
The 13C NMR spectra (Figure 3.4) for OCP-SUC indicate there are two major 
environments for the carboxylate and methylene carbons. In order to determine whether 
these peaks are due to a single succinate environment or two different (symmetric) 
succinate molecules, 13C-labelled OCP-SUC was synthesised, and 2D 13C-13C 
homonuclear correlation and SQ-DQ correlation experiments were performed. 
Unfortunately, the resolution of the spectra were not sufficient to extract information 
about the connectivity of the methylene carbons, so whether the signals are from one 
succinate molecule or two cannot be determined by this experiment. But the 
homonuclear correlation spectrum (Figure 3.10) shows the carboxylate at 184 ppm is 
correlated to the methylene at 34 ppm, and the carboxylate at 183.3 ppm is correlated 
to the methylene at 33.4 ppm, which indicates that the 184 ppm carboxylate 13C is 
connected to the 34 ppm methylene 13C, and the 183.3 ppm carboxylate 13C is 
connected to the 33.4 methylene 13C. 
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Figure 3.10. 13C-13C Homonuclear correlation spectrum for 13C labelled OCP-SUC, 
showing the correlation between the carboxylate 13C and methylene 13C. 
13C{31P} REDOR experiment was used to investigate the spatial relationship between 
carbon (succinate) and phosphorus (inorganic phase) nuclei within the OCP-SUC. The 
REDOR spectrum for OCP-SUC (Figure 3.11) shows dephasing for all the carbon 
peaks, although by different extents. This confirms that the all succinates are 
incorporated inside the OCP structure, and suggests that the two carboxylate 13C 
environments also have different distances to the surrounding phosphorus atoms. The 
REDOR dephasing curves (Figure 3.12) show that all four 13C environments have 
different dephasing rates, and that the carboxylate 13C signals dephase faster than those 
of the methylene carbons, which is consistent with a model in which the carboxylates 
chelate the calcium ions in the apatitic layer, and are hence closer to phosphorus atoms 
than the methylene carbons. The difference in dephasing rates also suggests that the 
carboxylate 13C at 184 ppm is connected to the methylene 13C at 34 ppm, and the 
carboxylate 13C at 183.3 ppm is connect to the methylene 13C at 33.4 ppm. This result 
is consistent with the finding from the 13C-13C homonuclear correlation experiment.  
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Figure 3.11. 13C{31P} REDOR spectrum for OCP-SUC. Red: reference, Blue: REDOR 
dephased. The dephasing time is 100 rotor periods. 
 
Figure 3.12. 13C{31P} REDOR dephasing curves. The 13C signals shown in Figure 3.11. 
The carboxylate 13C signals diphase faster than the methylene 13C, indicating that the 
carboxylate 13C have closer proximity to the 31P nuclei than the methylene 13C. 
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Considering all the information, the OCP-SUC structure should have the following 
features: 
 Similar phosphorus sites to OCP 
 The P5 phosphate groups substituted by succinates. 
 A unit cell with a centre of symmetry (or close to having a centre of 
symmetry)  
 Two succinates in a unit cell 
 Carboxylate-phosphorus distances different for different carboxylate 
environments (as depicted by 13C chemical shifts). 
Considering the above features, we propose a structural model (Figure 3.13), which has 
been modified from Model I of Markovic et al.121 It has two succinates oriented 
vertically across the hydration layer, but rather than positioned centrally within the 
hydrated layer, the succinates are staggered so that one COO¯ is closer to the nearby 
apatitic layer, and one further away, so as to be consistent with the REDOR NMR data. 
 
 
Figure 3.13. Proposed model for OCP-SUC (right), modified from Model I (left) 
proposed by Markovic et al.121 
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3.2.2 Structure modelling 
A model of OCP-SUC was constructed by substituting the P5 phosphate group of OCP 
with a succinate 2− anion, where one of the carboxylate groups is occupying the P5 
phosphate space. The model was then geometry optimised using CASTEP126 without 
any symmetry constraints, and the NMR parameters and PXRD pattern of the optimised 
model structure was calculated, and then compared with the experimental data. The 
optimised structure is shown in Figure 3.14, with labelling of phosphorus and carbons, 
which are used subsequently when describing the model. 
The optimisation of the structure is performed at 0 K, and this may cause differences 
between calculated and experimental NMR and XRD data, which were recorded in 
room temperature structures. From the NMR experimental data, the unit cell of OCP-
SUC is expected to be close to centrosymmetric, but the optimised structure is not. This 
may be due to fixation of the water molecules at 0 K for the calculation, whereas at 
room temperature, the water molecules in the hydrated layer are mobile, and the 
dynamics at the NMR time scale average to give an effectively symmetric structure. 
The calculated unit cell of OCP-SUC (Table 3.1) is expanded in the a-axis compared to 
OCP, which is expected as succinates were placed within the structure, and expanded 
across the hydrated layer. The calculated unit cell for OCP-SUC and OCP has d100 
values 6.1 % and 5.6 % greater than the experimental measurements respectively. The 
mismatch of the data may due to the fact that the calculation was performed at 0 K, at 
which the water molecules are frozen, and cause expansion of the unit cell. 
The distances between the carboxylate 13C and the nearest phosphorus nuclei are shown 
in Table 3.2. The P1 and P4 phosphorus atoms are in the apatitic layer, and too far away 
from the succinates to cause effective REDOR dephasing, and are therefore not incudal. 
C4 and C5 have shorter average distances to phosphorus nuclei than C1 and C8. The 
optimised structure has the same succinate arrangement as the proposed model in 
Figure 3.13, where the two carboxylates in the same succinate anion are at different 
distances away from the nearest apatitic layer. The geometry optimisation did not force 
symmetry on the structure, resulting in an unsymmetrical arrangement of the two 
succinates, predicting therefore that individual carbon atoms and phosphorus sites in 
this structure should have different NMR chemical shifts. 
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Figure 3.14. The unit cell of the geometry optimised model of OCP-SUC. Atoms that 
positioned ± 10% outside the centre unit cell in b-axis are shown. The structure has 
succinate 2− anion in the place of P5 phosphates, which are placed vertically across 
the hydration layer. The structure contains 10 water molecules. 
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Table 3.1. Lattice parameters of the unit cell of OCP-SUC and OCP. Geometry 
optimised at 0 K. 
 OCP-SUC / Å OCP / Å  OCP-SUC / ° OCP / ° 
a 22.67 (21.36)* 19.81 (18.76)* α 90.17 90.35 
b 9.71 9.52 β 98.12 93.3 
c 6.84 6.86 γ 104.52 109.99 
*the values inside brackets are the experimental values determined from PXRD. 
 
Table 3.2. Distance of carboxylate carbons to the nearest phosphorus.  
Distance / Å 
Phosphorus site 
Pb P2 Pa 
Carbon 
label 
C1 6.66 5.56 5.57 
C4 5.26 5.15 5.31 
C5 4.42 5.90 5.33 
C8 6.36 6.35 5.58 
 
Table 3.3. Calculated and experimental 13C NMR chemical shifts for OCP-SUC. 
 
Carboxylate Methylene 
C4 / C5 C1 / C8 C3 / C6  C2 / C7 
SUC1 (DFT)* / ppm 192.58 188.35 32.96 32.44 
SUC2 (DFT)* / ppm 185.27 189.75 32.34 31.12 
Experimental / ppm 184.3 183.3 33.4 34 
 
The NMR calculations for the 13C chemical shifts of succinate anion (Table 3.3) show 
good agreement with the experimental data, particularly for the methylene carbons. 
This confirms the placement of succinates in the hydrated layer. The C1 / C8 
carboxylates, which are the two that are further away from apatitic layers, show the 
largest mismatch between calculation and experiments. The chemical shifts are affected 
by the hydrogen bonding of the nearby water in the hydrated layer and binding strength 
of the carboxylate coordination to nearby calcium atoms. The calculated structure has 
the water molecules fixed at 0 K, therefore the hydrogen bonding environments will be 
different to those at room temperature. The a-axis of the unit cell for the calculated  
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Table 3.4. Calculated and experimental 31P chemical shifts of OCP-SUC. Top refers to 
the upper apatitic layer in Figure 3.14, and bottom to the lower one. 
  P1 P2 P4 Pa Pb 
Top (DFT)* / ppm 5.24 2.18 1.98 0.11 -3.5 
Bottom (DFT)* / ppm 2.71 2.41 6.71 -1.56 -5.01 
Average (DFT) / ppm 3.98 2.30 4.35 -0.73 -4.26 
Experimental / ppm 3.13 1.89 3.44 -0.31 -1.33 
*the NMR chemical shifts are extrapolated to 273 K. 
 
 
Figure 3.15. 13C{31P} REDOR dephasing curves for the carboxylate 13C of OCP-SUC. 
Solid lines are simulated from the model structure: C1 (blue), C4 (brown), C5 (red), 
and C8 (yellow). The data points are collected from the REDOR spectra (Figure 3.11) 
of synthesised OCP-SUC: 184 ppm peak (purple) and 183.3 ppm peak (black). 
structure is larger than for the structure at room temperature. This causes the C1 / C8 
carbons to be further away from their closest apatitic layer at 0 K and will have two 
effects: one is to accommodate more water molecules in the hydrated layer, the other 
is to impose a greater distance between these carboxylates and apatitic layer (calcium 
and phosphate groups). Such interactions are expected to have less effect on the other  
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Figure 3.16. 13C {31P} REDOR dephasing curves for the C1 and C8 carboxylate 13C of 
OCP-SUC before and after compression of the a-axis. Dark solid lines are simulated 
from the model structure: C1 (blue) and C8 (green). Light solid lines are simulated 
from the model structure with reduced a-axis length: C1 (blue) and C8 (green). The 
data points are collected from the REDOR spectra (Figure 3.12) of synthesised OCP-
SUC: 184 ppm peak (purple) and 183.3 ppm peak (black). 
two carboxylates (C4 / C5), because they are strongly coordinated to their nearby 
apatitic layers, and the expansion of a-axis at 0 K will not affect the distance between 
them (C4 / C5) and surrounding nuclei. 
Due to the lack of symmetry of the calculated structure, 10 different 31P NMR chemical 
shifts are predicted rather than the 5 observed experimentally. At room temperature, the 
experimental NMR data suggests the structure is close to centre symmetric. This may 
be facilitated by molecular dynamics of e.g. hydrated layer H2O molecules, absent in 
the 0 K calculation. The sites that the model structure predict for each phosphorus may 
be among the possible sites at room temperature, and the experimental NMR data 
represents the time average across all the sites. Therefore, the predicted NMR chemical 
shifts for each phosphorus site have been averaged and used for the comparison with 
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experiment. The average calculated 31P NMR chemical shifts have the expected pattern, 
with orthophosphates having higher chemical shifts than the hydrogen phosphates.  
Besides structural imperfection, two other major factors contribute to the mismatch of 
the calculation and experimental values of the 31P NMR chemical shifts.  
Immobile water and an expanded hydrated layer will have a considerable effect on the 
environments of phosphorus close to the apatitic/hydrated layer interface, i.e. Pa, Pb and 
P2. In particular the Pb phosphorus atoms are expected to show the largest discrepancy, 
due to their closest proximity to the hydrated layer. 
The correlation formula for extrapolating chemical shifts from 0 K to 273 K was 
determined by comparison between the chemical shift of calculated and experimental 
value of HAp. Therefore, depending how close the OCP-SUC system is to HAp, there 
may be a systematic offset. The P1 and P4 sites are within the apatitic layer, so should 
had the least effect from the water molecules. The averages of the P1, and P4, chemical 
shifts have around + 0.9 ppm offset from experiment, which implies that the OCP-SUC 
system has a systematic offset from the extrapolation formula used.  
13C{31P} REDOR dephasing curves (Figure 3.15) have been simulated using the 
distance data obtained from the optimised structure (Table 3.2). In all cases, the 
experimental dephasing curves dephase faster than the ones calculated from the model 
structure, indicating that at room temperature at least, the 13C-31P distances are 
generally shorter than these in the 0 K model structure, i.e. the unit cell structure at 
room temperature is somewhat compressed along the a-axis compared with the 0 K 
model structure. So to estimate the REDOR dephasing curve at room temperature, the 
distances from C1 and C8 carbon to nearby phosphorus were reduced by 0.7 Å, and the 
simulated curves are plotted in Figure 3.16. The difference between the 0K model and 
room temperature experimental a-axis length is 1.31 Å. Use of 0.7 Å is only an 
estimation, as the carboxylate 13C-31P axes are not parallel with the a-axis, so the 
distance reduced by shrinking the unit cell will be less than the full difference. Also, 
the change in 13C-31P axes orientations when the unit cell shrinks was not taken into 
account in the REDOR curve simulations, as the distance effect will be dominant. The 
new curves show better agreement with the experimental ones, indicating that 
compressing the unit cell a-axis to towards that measured experimentally produces a 
model predicting the correct carboxylate carbon – phosphorus distance.  
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Figure 3.17. 43Ca DOR NMR spectra for 43Ca-enriched OCP (blue) and OCP-SUC 
(black), and 43C NMR spectrum for 43Ca-enriched OCP-SUC (red). The coloured bars 
are the calculated 43Ca NMR chemical shifts for OCP-SUC. The DOR (black) spectrum 
for OCP-SUC shown significant improve in resolution compare to spectrum acquired 
in MAS (red), by removing the 2nd order quadrupolar coupling. 
The 43Ca DOR spectra for OCP and OCP-SUC were recorded (Figure 3.17) to 
investigate the calcium environment of the samples. The spectra show very similar 43Ca 
chemical shifts for OCP and OCP-SUC. There are at least eight calcium sites identified 
on the OCP-SUC spectrum, which is expected from the structure of OCP. The 
calculated 43Ca NMR chemical shifts are in good agreement with the experimental data 
in terms of the range of the spectrum, and have good representations of most peaks. 
However, the calculated values do not cover 0 – 10 ppm range, suggesting there may 
be some environments not reproduced in the model structure. 
In summary, the 0 K model structure broadly reproduces the experimental NMR data, 
and the NMR REDOR data when the unit cell is compressed along the a-axis in line 
with the d100 distance measured by PXRD. 
Here we have assumed there is one major crystal structure for the OCP-SUC, i.e. the 
two different environments for carboxylate and methylene carbons from the 13C CP 
spectrum are due to a single succinate molecule. However, other possibilities may also 
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exist, for example, the two methylene/carboxylate environments might be due to two 
different unit cell configurations, with the succinates in the same unit cell have equal 
distance to the phosphorus atoms.  
3.2.3 Comparison of OCP-metabolite composites 
Adipate, citrate, formate and lactate (chemical structures are shown in Figure 3.18) 
were successfully incorporated into the OCP structure to produce OCP-ADI, OCP-CIT, 
OCP-FOR and OCP-LAC. OCP-citrate lactate (OCP-CL) and OCP-citrate formate 
(OCP-CF) were also synthesized. The chemical analyses of these compounds are shown 
in Table 5, together with the d100 spacing determined from PXRD diffractograms. All 
the compounds have 2:1 calcium to phosphorus ratios, which is similar to OCP. This 
suggested that all compounds have an inorganic phase that resembles OCP and that the 
metabolites are substituted / inserted into the OCP structure.  
 
 
 
Figure 3.18. Chemical structures of the metabolites that incorporated into the OCP 
structure. 
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Table 3.5. Chemical analysis and d100 spacing (measured by PXRD) of the OCP-
metabolite composites. 
Compounds 
Elements / wt% 
No. of C / 
unit cell 
No. of P 
/ unit 
cell 
d100 / 
Å C H Ca P 
OCP-SUC (C4)‡ 4.26 1.48 31.60 15.13 8.7 9.9 21.36 
OCP-ADI (C6)‡ 6.11 1.77 30.09 14.45 10.8 9.9 23.59 
OCP-CIT (C6)‡ 3.58 1.65 29.81 15.51 6.4 10.1 21.99 
OCP-FOR (C1)‡ 1.39 0.63 32.79 17.98 2.3 11.3 18.63 
OCP-LAC (C3)‡ 2.53 0.86 30.86 16.99 4.4 11.4 18.81 
OCP-CF  5.14 1.43 31.27 14.07 8.8 9.3 22.31 
OCP-CL 3.36 1.02 30.67 15.81 5.8 10.6 - 
d100 for OCP is 18.76 Å 
‡: Number of carbon atoms in a substituted organic acid. 
 
Chemical analysis 
The chemical analysis results and the d100 spacing data measured by PXRD are shown 
in Table 3.5. The number of carbon and phosphorus atoms per unit cell are calculated 
by assuming there are 16 calcium atoms per unit cell. The carbon composition predict 
that OCP-CIT has one citrate molecule per unit cell, which agrees with previous studies. 
OCP-SUC, OCP-ADI and OCP-FOR all have two organic acid molecules per unit cell 
from the carbon analysis (Table 3.5). It is expected that OCP-SUC and OCP-ADI will 
have very similar structures, due to the structural similarity between the two organic 
acids, with adipate substituting the P5 phosphate group and have analogous orientation 
like succinates in OCP-SUC. Similarly, it is expected that the formate and lactate are 
substituting the P5 sites, but due to the small size of these two acids, instead of 
substitution, they may also be added as mobile molecules in the hydrated layer or close 
to the apatitic layer.  
The carbon content is around 10% higher than the theoretical values in all cases (e.g. 
theoretically there should be 8 carbon atoms per unit cell for OCP-SUC, but 
experimentally there are 8.7). This may due to carbonate contamination, and attachment 
of the metabolites to crystal surfaces, both of which would elevate the carbon content. 
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For the double metabolite composites (OCP-CF and OCP-CL), there are two likely 
structural arrangements. The two different metabolites A and B can either occupy the 
same unit cell, i.e. all the unit cells have the same chemical composition OCP-A+B, or 
the two metabolites are in different unit cells, i.e. the compound is a mixture of OCP-
A and OCP-B. 
The OCP-CF has 8.8 carbon atoms per unit cell, which equals the sum of OCP-CIT and 
OCP-FOR, consistent with the citrate and formate occupying the same unit cell. OCP-
CL has 5.8 carbon atoms per unit cell, which is less than the OCP-CIT value, but more 
carbon atoms per unit cell than OCP-LAC. This suggested that the citrates and lactates 
are in separate unit cells, with around a 2:1 ratio OCP-CIT to OCP-LAC; the number 
of phosphorus atoms per unit cell agrees with this hypothesis. This amorphous state of 
OCP-CF may be the reason that the d100 peak cannot be measured by the PXRD.    
The number of phosphorus atoms per unit cell suggest that OCP-SUC, OCP-ADI and 
OCP-CIT have two phosphate groups replaced by the metabolites, in agreement with 
prediction. OCP-FOR and OCP-LAC have only one phosphate group substituted, while 
there are two metabolites present per unit cell, suggesting that one of acids is 
incorporated as an addition rather than substitution, which can be achieved due to their 
small size. OCP-CF has three phosphate groups substituted by the metabolites. 
Considering the OCP-CIT and OCP-FOR results, it appears that citrate will occupy two 
of the P5 sites, with one formate substituting another site, very likely P6 due to its 
proximity to the hydrated layer. The other formate may be free in the hydrated layer.  
The d100 spacing is generally expanded due to incorporation of the metabolites, and the 
larger the acid is, the greater the expansion. The difference in the d100 spacing between 
OCP-SUC and OCP-ADI is 2.24 Å, comparable to the length of two methylene carbon 
units (2.5 Å), suggesting that the adipate and succinate have very similar orientations 
within the structure. The d100 spacing for OCP-FOR and OCP-LAC are very similar to 
OCP, due to the similar size of formate and lactate to phosphate, so substitution does 
not cause sizable expansion of unit cell.  
The OCP-CF has slightly larger d100 spacing than OCP-CIT. Considering that 
substitution of the P5 phosphate group by formate causes shrinking of the unit cell 
(OCP to OCP-FOR), this indicates that inclusion of formate molecules when citrate is 
also present occurs via a different mechanism. As discussed earlier, citrate substituted  
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Figure 3.19. 31P DP spectra of OCP-metabolite composites. 
at the two P5 phosphates, so the next possible substitution site is the P6 phosphates 
(OCP). The P6 phosphates are closer to the apatitic layers than P5, so such substitution 
will affect the overall apatitic structure as well as the hydrated layer. There is also 
addition of one formate molecule in the hydrated layer. Compared to OCP-FOR, where 
only formate is included in the hydrated layer in OCP-CF, the citrate anions have a 
CH2COO¯ chain placed in the same region and must compete for space with the 
formate anions, and this may be the cause of expansion of the unit cell. 
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Figure 3.20. SQ-DQ correlation for OCP-SUC (left) and OCP-ADI (right). 
31P NMR spectra 
The 31P DP spectra for the OCP-metabolite composites are shown in Figure 3.19. It is 
clear that OCP-SUC and OCP-ADI have sharper and “cleaner” spectra than the others, 
and show considerable similarity to OCP (Figure 3.5). Both succinate and adipate are 
symmetric, linear molecules with an even number of carbon atoms. Therefore it is 
possible to preserve the symmetry of the OCP unit cell when they are substituted into 
the unit cell structure. The only difference between the two 31P spectra is that OCP-ADI 
has slightly higher chemical shift for the hydrogen phosphate, Pb, than OCP-SUC, 
corresponding to weaker interaction between the Pb phosphate and hydrated layer water 
molecules. The 2D 31P SQ – DQ correlation (Figure 3.20) and 1H-31P HETCOR spectra 
(Figure 3.21) show virtually the same pattern, indicating very similar environments for 
phosphorus between OCP-SUC and OCP-ADI, and indicating that adipate are 
substituted in a similar manner to succinate and that the apatitic framework is very 
similar in the two composites.  
The other metabolites are branched and do not possess a high degree of symmetry, 
which causes loss of the unit cell centre of symmetry, and consequentially results in 
many different phosphorus environments which causes broadening of the 31P signal in 
NMR spectra. The metabolite incorporation causes a dramatic loss of the hydrogen 
phosphate 31P NMR signal intensity. The broadened 31P signal in the hydrogen 
phosphate region extends to ~ -3 ppm, indicating that such environments still exist in 
the structure. The orthophosphate 31P signal around 2.9 – 3.4 ppm is in the  
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Figure 3.21. 2D 1H-31P HETCOR for OCP-SUC (left) and OCP-ADI (right). 
chemical shift range of the P1/P4 orthophosphates of OCP. The OCP-CIT and OCP- 
FOR appear to have less P4 intensity than the other three compounds. OCP-CIT, OCP-
LAC and OCP-CF have 31P signals around 1.4 – 1.8 ppm, corresponding to the P2 site 
of OCP. The citrate-containing compounds have lower 31P chemical shifts for this site 
relative to OCP, whereas OCP-LAC has the same shift, indicating stronger association 
of the phosphate site to water, presumably as a consequence of an increase in water 
content due to the unit cell expansion.  
The 1H-31P HETCOR NMR spectra for OCP-CIT, OCP-LAC, OCP-FOR, OCP-CL and 
OCP-CF (Figure 3.22) have very similar overall patterns, with similar ranges of 31P and 
1H environments. All of them have a strong apatitic orthophosphate signal close to 3 
ppm. The citrate containing samples have strong signals around 1.7 ppm, corresponding 
to the P2 site of OCP, which is the orthophosphate close to water, and have broad 
contours extending into the hydrogen phosphate region. The OCP-LAC and OCP-FOR 
have more pronounced signals at −0.4 ppm, corresponding to hydrogen phosphate 
groups, while the 1.7 ppm signal is much weaker and less clear, indicating that the 
hydrogen phosphate environments are most affected by the inclusion of a large, 
complex molecule such as citrate. 
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Figure 3.22. 1H-31P HETCOR spectra of OCP-metabolites. 
13C NMR spectra 
The 13C CP (Figure 3.25) and 13C{31P} REDOR (Figure 3.26) experiments confirmed 
the incorporation of the metabolites into the OCP structure. OCP-ADI has very sharp 
13C signals, indicating symmetry in the unit cell and ordered adipate arrangement within 
the structure, as in OCP-SUC. Moreover, the OCP-ADI 13C spectrum also shows two 
peaks for each carbon type. This pattern can be explained with the same argument as 
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for OCP-SUC, either by asymmetric placement of the adipate molecule (similar to the 
structural model in Figure 3.14), or two different adipate environments with centre 
symmetry for individual molecules. The REDOR dephasing curves of OCP-ADI 
(Figure 3.24) also show a similar pattern to those of OCP-SUC, with the two 
carboxylate peaks having different dephasing rates, corresponding to different 
separations from the apatitic layer. The methylene carbons signals also have different 
dephasing rates, the two central atoms being slowest, as expected as they should be 
furthest away from the apatitic layers and 31P nuclei. The chemical similarity of 
succinate and adipate, as well as the similarity of their respective NMR spectra, shows 
the OCP-ADI unit cell structure to closely resemble that of OCP-SUC, with simple 
substitution of succinate by adipate, and expansion in the a-axis due to increase in the 
molecular length. 
The other compounds shown much broader 13C signals relative to OCP-SUC and OCP-
ADI, indicating disorder of the metabolites within the OCP structure. The OCP-FOR 
spectrum has a very weak signal to noise ratio (recording a satisfactory REDOR 
spectrum was not possible) due to inefficient CP, most likely because of formate 
mobility within the structure. 
Nevertheless much information can be extracted from the 13C spectra despite the signal 
broadness. There are three distinct carboxylate environments for OCP-CIT, at 179.6 
ppm, 181.9 ppm and 182.7 ppm, most likely corresponding to the three carboxylate 
groups of the citrate anion. These three environments are retained in OCP-CF; the 179.6 
ppm remains at the same chemical shift, but the other two have increased by ~0.2 ppm. 
The same effect is observed in OCP-CL, with the 179.6 ppm peak shift decreased by 
~0.3 ppm (with significant broadening), while the other two increase by ~0.5 ppm. The 
change in chemical shifts may due to the presence of a citrate anion and a 
formate/lactate anion in the same unit cell, or that the neighbouring unit cells have 
different sizes due to incorporation of different metabolites. In order to adapt to this 
environment, the citrate-containing unit cell in OCP-CL and OCP-CF would have 
different dimensions from the unit cell of OCP-CIT, which will lead to shifts in the 
carboxylate 13C chemical resonances. 
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Figure 3.23. 13C CP spectra, showing the comparison of the citrate quaternary and 
methylene carbon NMR spectral region in OCP-CIT, OCP-CF and OCP-CL. The 
reduction in intensity of signals at 43.4 ppm, 42.5 ppm and 74.6 ppm indicate that the 
presence of lactate and formate cause loss of some distinct citrate environments.  
 
Figure 3.24. REDOR dephasing curve for OCP-ADI 
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Figure 3.25. 13C CP spectra of OCP-metabolite composites. 
The addition of formate or lactate to the OCP-CIT also affects the quaternary and 
methylene carbon spectral region. As shown in Figure 3.23, there is a disappearance of 
74.6 ppm shoulder in both OCP-CL and OCP-CF, and disappearance of 43.4 ppm and 
42.5 ppm methylene signal components in OCP-CL (OCP-CF shows reduced intensity 
for these two signals, but the features are still observable). The signal intensity  
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Figure 3.26. 13C{31P} REDOR spectra of OCP-metabolites. The reference spectra are 
in red, and the REDOR spectra are in blue. 
integration shows similar intensity ratio between the quaternary region and the 
methylene region, indicating that all the citrate signals are preserved, and the loss of 
intensity is not due to inefficient CP. Overall, the inclusion of formate or lactate into 
OCP-CIT sharpened the citrate signals and reduced the range of possible citrate 
environments, suggesting the two metabolites are competing for space within the unit 
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cell, and possibly restricting certain environments for the branched citrate molecule in 
the hydrated layer.  
The 13C CP spectrum for OCP-CL shows stronger intensity for citrate than lactate, 
which supports the 2:1 ratio of OCP-CIT to OCP-LAC proposed in the discussion of 
the chemical analysis of OCP-CL. The comparison of the citrate peaks to those OCP-
CIT shows the effect of lactate on the organisation of the citrate anions in the hydrated 
layer, indicating that the OCP-CIT and COP-LAC are not in separate phases. The OCP-
CL consists of amorphous distribution of OCP-CIT and OCP-LAC unit cell throughout 
the composite. The difference in the unit cell dimensions of OCP-CIT and OCP-LAC 
unit cells may cause unit cells to adapt the neighbouring unit cell, which will cause 
disruption, and effect the NMR signals of the metabolites. 
43Ca NMR spectra 
The 43Ca NMR spectra for HAp, OCP and different OCP-metabolite composites are 
shown in Figure 3.27. The spectra for all the OCP-metabolites and OCP have similar 
43Ca chemical shift ranges, from −20 to +30 ppm. The spectra for OCP, OCP-SUC and 
OCP-ADI have very similar lineshapes, with the main peak between −10 and 0 ppm. 
The citrate, lactate and formate containing composites show stronger intensity between 
0 and 15 ppm, and a broader peak range from −10 to 15 ppm. This suggests that the 
calcium environments corresponding to the 0 – 15 ppm chemical shifts are more 
abundant in citrate, lactate and formate containing composites. Interestingly, this region 
is also not predicted by the calculated 43Ca chemical shifts.  
 
Considering all the data, and our structural models of OCP-SUC and OCP-CIT, 
possible models of OCP-ADI, OCP-FOR, OCP-LAC, OCP-CF and OCP-CL can be 
proposed. 
The OCP-ADI is analogous to OCP-SUC, with two adipate molecules substituting both 
P5 sites, and oriented vertically across the hydrated layer. The two carboxylate groups 
on each adipate are at different distances from the apatitic layer, to yield the 
corresponding REDOR dephasing pattern. 
The OCP-LAC and OCP-FOR have one of the metabolite molecules substituting a P5 
site, with the other mobile in the hydrated layer. 
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Figure 3.27. 43Ca NMR spectra for HAp, OCP, and OCP-metabolite composites. 
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The OCP-CF has one citrate molecule and two formate molecules per unit cell 
consistent with the chemical analysis. The citrate is oriented across the hydrated layer 
similar to OCP-CIT, but movement of the side branch in the hydrated layer is more 
restricted due to the presence of the mobile formate molecules. 
The OCP-CL very likely consists of amorphous state of OCP-CIT and OCP-LAC unit 
cells. 
3.2.4 Looking for the metabolites – leaching experiment 
A leaching experiment was carried out to identify metabolites that have been trapped 
inside bone mineral. Adult sheep bone powder was dissolved in HCl over several days, 
and the supernatant was examined at selected time points with solution-state 1H NMR 
spectroscopy; typical spectra are shown in Figure 3.28. 
All of the spectra show similar broad “background” signals, probably due to lipids, 
sugars, and proteins or protein fragments. An abundance of lactate was only observed 
at day 1, and not at later time points, suggesting either that lactate can be very easily 
removed from the mineral, or that this lactate comes from bone cells. The fact that the 
bone sample was stored in ethanol explains the observation of varying levels of ethanol 
at different time points.  
The citrate signals were observed from day 4, and gradually decrease in intensity in 
spectra at later time points, suggesting that citrate is strongly bonded and integrated into 
the bone mineral structure, as it takes at least four days of acid leaching for it to be 
released. Thus, the citrate 1H signals may be effective markers of those time points at 
which small organic molecules included in the bone mineral start to be released into 
solution, and so that any signals that appear after day 4 are potentially within the mineral 
structure.   
Chapter 3: Characterisation of OCP – metabolite Composites 
80 
 
 
Figure 3.28. Solution state 1H NMR spectra of supernatants of adult sheep bone 
dissolved in HCl for different lengths of time. i) Lactate was clearly observed after day 
1, but not thereafter. ii) Citrate only appeared in the supernatant at day 4 (blue), and 
its abundance decreases at day 7 (green) and day 16 (red).  
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3.3 Summary 
Succinate, citrate, formate and lactate were successfully incorporated into OCP, to 
create OCP-metabolite composites as model systems to aid an understanding of the 
structure of bone mineral. ssNMR was applied to understand the relationships between 
the metabolites and OCP, and DFT methods were employed to construct a structural 
model for OCP-SUC. 
Possible models for OCP-ADI, OCP-FOR, OCP-LAC, OCP-CF and OCP-CL are 
proposed using the experimental data and with the aid of structural models of OCP-
SUC and OCP-CIT.
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Chapter 4:                         
Dissolution of Octacalcium 
Phosphate - Metabolite Composite 
 
Many metabolites circulate in the extracellular fluids and are involved in cellular 
processes within the bone. In Chapter 3, it was shown that several different metabolites 
can be incorporated into the OCP structure, raising the possibility that they are present 
in the bone mineral itself. 
Healthy bone relies on remodelling processes to repair damage and maintain function. 
Remodelling requires a fine balance between osteoclastic bone resorption and 
osteoblastic bone formation.55 If the bone mineral solubility depends on chemical 
composition, for instance on account of the metabolites trapped within the mineral 
structure, then a more soluble mineral would lead to resorption of a larger volume than 
normal bone, with osteoblasts potentially unable to fill the resulting cavity resulting in 
a more porous structure which will be weaker and fragile. 
To test whether incorporation of different metabolites can in principle affect the 
solubility of bone, the OCP-metabolite composites prepared earlier are used as model 
compounds and their dissolution rates are compared. 
Many factors affect the solubility of a material, such the method of sample preparation, 
the resultant crystallinity and density of the sample, and the extent of ionic substitutions 
in the lattice. Ionic substitution disrupts the unit cell structure and, in turn, alters the 
dissolution properties of the material in solution. Some ionic substitutions such as 
carbonate are known to increase the solubility of apatites,127 while fluoride substitution 
into the apatite lattice decreases solubility.128 Similarly, the degree of crystallinity 
affects the solubility of apatites. Highly crystalline apatites tend to be very insoluble, 
while poorly crystalline apatites have higher relative solubilities.129,130 
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Dissolution mechanism 
Different models have been developed to simulate the dissolution process under 
different conditions. These models propose mechanisms by which the properties of the 
solution (pH, composition, saturation and hydrodynamics), bulk solid (chemical 
composition, solubility, particle sizes) and surface (defects, adsorbed ions, phase 
transformation) may affect the dissolution process.  
A general dissolution mechanism for calcium apatite under acidic conditions has been 
proposed by unifying different dissolution models (Figure 4.1).131 The first step is that 
of water molecules and acid ions contacting the solid and adsorbing to the surface, and 
simultaneously forming a solid/liquid interface, and various layers such as the Nernst 
diffusion layer, electrical double layer, etc. In acidic conditions, an electric double layer 
is formed, and the surface is positively charged.  The thickness of these layers depends 
on the solution hydrodynamics and the dimensions of the dissolving solid. As chemicals 
diffuse through these layers, adsorption of ions (H+ and An−) on to the solid surface 
forms various complexes. The positively charged species (H+) attach to the 
orthophosphate to form HPO4
2− and may then “jump” to other anions such as OH−, and 
negatively charged anions may adsorb onto calcium cations. Dissolution occurs by 
detachment of so-called X-ions (OH− and ionic substitutes for OH−) due to their 
relatively high mobility, and ease of substitution to form intermediate compounds.132–
134 Different substitutions result in different dissolution kinetics, resulting in difference 
in solubilities within the material.135 The detachment causes holes in the positively 
charged electric double layer, and enables interaction between calcium cations and 
anions of acid adsorbed from solution, which results in release of the surface calcium 
ions, and their diffusion away into the bulk solution. After removing calcium cations, 
there are fewer forces to hold the phosphate groups in place, and when most of the 
neighbouring calcium cations have been removed, the phosphate group also detaches 
from the surface. Thus, the vacant sites act as nuclei for dissolution, which propagates 
from here. 
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Figure 4.1. Schematic diagram shown the proposed mechanism of dissolution of apatite 
in acidic solution. 1). Formation of a double layer upon the contact between solid and 
solution. Species transport through the layer is governed by ionic concentration 
gradients. The surface of the solid is positively charged, with proton attached to the 
phosphate groups. 2). Detachment of mobile species (X-ions) from the solid surface 
creates hole on the positively charged surface. 3). Adsorption of anions to the surface 
calcium is increased due to the ‘holes’ from the second step. This results in breaking of 
the Ca-O bonds and detachment of calcium ions. 4). Detachment of calcium ions leaves 
phosphate groups exposed, resulting in their release into the solution. Detachment of 
surface atoms results defects on the solid surface which act as nuclei for further 
dissolution, repeating steps 2 – 4. 
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4.1 Experimental 
4.1.1 Sample preparation: 
Five different materials were used in this study: OCP, OCP-SUC, OCP-CIT, OCP-LAC 
and adult cryo-milled sheep bone powder. Samples were pressed into cylindrical pellets 
(~330 mg, 13 mm diameter, 1.0 mm thickness) using a Specac Manual Hydraulic Press 
under 10 tons pressure for 10 minutes, and used immediately for the dissolution 
experiment without further treatment. 
4.1.2 Dissolution experiments 
Acetic acid buffer (0.087 M) at different pH values (4.0, 4.5 and 5.0) was used in this 
experiment. At each pH, three pellets of same material were suspended at the centre of 
separate 50 ml beakers in glass baskets (see experimental setup in Figure 4.2). Each 
beaker contained 40 ml of the buffer and tetraphenylphosphonium bromide (~1.0 mM) 
as an internal concentration reference. The solution was stirred with a magnetic stirrer 
at 90 rpm. At each of the following time periods: 5, 15, 25, 50, 90, 180, 300, 600 and 
1440 minutes (unless otherwise stated), one 2.0 ml aliquot of solution was taken for 31P 
solution-state NMR measurements to determine the phosphate ion concentration. A 
Bruker 500 MHz Avance III HD spectrometer and dual resonance broadband observe 
probe was used for the 31P solution-state NMR measurements, at a frequency of 202.48 
MHz (field strength 19.2 kHz), with 10% D2O as solvent. The phosphate ion 
concentration was calculated by integrating the area under the peak, and referenced to 
the concentration of tetraphenylphosphonium bromide, and total recycle time of 3.3 s 
was used to ensure full relaxation of the species. 
For each pH value, the average of the three phosphate ion concentrations was used to 
plot the graph (concentration of phosphate ion against time). 
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Figure 4.2. Experimental apparatus setup for the dissolution experiment described in 
the text. The pellet of test material is suspended at the centre of the buffered solution by 
a glass basket. A hotplate and magnetic stirrer is used to generate a constant 
mechanical current. A parafilm cover is used to avoid evaporation during experiment. 
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4.2 Results and discussion 
According to the literature,48 bone resorption takes place at pH 4.5, which this study 
aims to mimic. Thus, dissolution rates of the OCP-metabolites was measured at pH 4.5, 
and the dissolution rates at pH 4.0 and pH 5.0 were also measured to assess pH 
dependence.  
The dissolution model described previously suggests that the rate of dissolution is 
affected by many different factors, of which the intrinsic solubility of the solid is only 
one. In order for the results to be comparable between samples, other significant factors 
were kept constant throughout all experiments as far as possible. The same 
concentration buffer and internal reference compound (with same concentration) was 
used throughout the experiment. The solution was stirred with the same model of 
hotplate stirrer at 90 rpm, to create a steady mechanical current which will be the major 
hydrodynamic effect in the surrounding solution, ensuring all the interface layers and 
diffusion rates of species across these interface layers were the same across all 
experiments. The solids used in the experiments were compressed into cylindrical 
pellets of the same dimensions. The glass basket used to hold the pellets at the centre 
of the solution was designed so that it is only the top surface of the pellet that is in 
contact with the solution to ensure that dissolution takes place mainly at a single, well-
defined surface (Figure 4.2). However, despite these efforts to control all variables, 
some factors were difficult to control. The hardness of the solid affects the integrity of 
the pellet. OCP-CIT appears to be harder after pelleting than the other composites, with 
a rougher surface which may provide extra dissolution nuclei. Another source of 
variability is the disintegration of the pellet in the solution as pellets “peel apart” on the 
surface after a few hours in solution. The process is faster in the low pH, potentially 
increasing the dissolution rate at lower pH. As the aim of these experiments is to 
compare the solubility of different OCP-metabolites composites at differently pHs, the 
absolute dissolution rate is less critical than the comparison of the dissolution rates 
between different materials. 
The dissolution curves for the different OCP-metabolite composites at pH 4.0, pH 4.5 
and pH 5.0 are shown in Figure 4.3, Figure 4.4 and Figure 4.5 respectively. Overall 
across all pH values, OCP-SUC has the fastest dissolution rate, and OCP the slowest  
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Figure 4.3. The dissolution of OCP-metabolite composites at pH 4.0. The OCP-SUC 
has the fastest rate, and OCP-LAC is the slowest. OCP, OCP-CIT and bone powder 
have similar dissolution rates. 
rate. OCP-LAC has the slowest rate at pH 4.0 and pH 4.5, and similar initial rate 
comparable to OCP-CIT and OCP-SUC at pH 5.0. The dissolution rate of bone is 
intermediate for all pHs.  
A bar graph of phosphate ion solution concentration at 300 minutes is shown in Figure 
4.6. The higher the concentration of the phosphate the faster the rate of dissolution. The 
same pattern as in Figure 4.6 is exhibited at other time points as well; this one was 
chosen for illustration because at early stages the phosphate ion level is low and the 
measurement error is large, and at later stages the rates slow down and the curves 
plateau. 
OCP-SUC, OCP and bone show a clear relationship between pH and dissolution rate, 
the rate decreasing as pH increases. This is predictable as there are fewer H+ ions in 
solution to facilitate the dissolution process. The pattern for OCP-LAC and OCP-CIT  
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Figure 4.4. The dissolution of OCP-metabolite composites at pH 4.5. The OCP-SUC 
has the fastest rate, and OCP-CIT is slightly slower than OCP-SUC. OCP and OCP-
LAC have similar rate, and are slowest. Bone dissolves slightly faster than OCP. 
is less clear, and within experimental error there is not much difference in dissolution 
rate in this pH range. It seems that the inclusion of citrate or lactate buffers the 
dissolution rate between pH 4.0 – 5.0. 
OCP has the most crystalline structure of the samples and is therefore predicted to have 
the slowest dissolution rate, and this is in agreement with the experimental results. The 
ssNMR data from Chapter 3 show OCP-SUC is also very crystalline, however it has 
faster dissolution relative to OCP-CIT and OCP-LAC, which are more disordered than 
OCP-SUC by ssNMR. There are two possible explanations for this. Firstly, the 
sharpness of the NMR spectra of OCP-SUC is due to the symmetric nature of the unit 
cell, which OCP-CIT and OCP-LAC lack. This means that even though OCP-SUC 
displays sharp NMR lineshapes, in terms of crystallinity it may not differ much from 
OCP-CIT and OCP-LAC. Also, mobility of water and variable hydrogen bonding 
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Figure 4.5. The dissolution of OCP-metabolite composites at pH 5.0. OCP-CIT, OCP-
LAC and OCP-SUC has similar dissolution rate at beginning, but they plateaued at 
different concentration. OCP has the slowest rate and bone is intermediate. 
interactions with the included metabolites, and proximity of phosphate groups to the 
hydrated layer, will contribute to the 13C and 31P NMR spectral lineshapes respectively. 
In terms of the apatitic structures, all three samples and OCP should be very similar. 
Secondly, the region with highest molecular mobility should be dissolved away first, 
and in the OCP-metabolite structures, this should be the hydrated layer. Molecules and 
ions in composites with larger hydration channels are expected to detach most readily 
due to larger solvent contact surfaces. Therefore, the samples with larger d100 
dimensions (Table 3.5) are expected to have faster dissolution rates, and indeed OCP-
SUC and OCP-CIT have faster dissolutions rates than OCP and OCP-LAC.  
Besides the structural differences between the OCP-metabolite composites, the 
properties of the organic acids are expected to affect dissolution mechanisms. Though 
from this simple experiment, it is not possible to propose detailed mechanisms by which  
0
1
2
3
4
5
6
7
0 100 200 300 400 500 600 700
P
h
o
sp
h
a
te
 i
o
n
 s
o
lu
ti
o
n
 c
o
n
ce
n
tr
a
ti
o
n
  
/ 
m
M
Time / mins
OCP-SUC OCP-CIT OCP OCP-LAC Bone
Chapter 4: Dissolution of OCP - metabolite Composite 
 
 
91 
 
 
Figure 4.6. Plot of phosphate ion concentration at 300 minutes for all samples across 
pHs. 
these metabolites may be involved in the dissolution process, the following factors are 
expected to be important: molecular dimensions, the predominant charged form of the 
organic acid at the pH of the experiment (Table 4.1), and affinity for calcium of the 
charged form of the organic acids, and the availability of hydroxyl groups of the organic 
acids to participate in secondary interactions. 
It would be expected that the stronger the binding between a metabolite and calcium, 
the more difficult it might be for both to be mobilised into solution. The size of the 
metabolite should affect the rate at which it diffuses away from the dissolution front 
and into the bulk solution. Once detached from the structure, the metabolite may remain 
involved in dissolution by further chelation and removal of surface calcium. The 
removed metabolite anion may also form an insoluble coating of calcium-metabolite 
complex on the surface to hinder the accessibility of the solid by the ions. 
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Table 4.1. The pKa of the organic acids and the predominant species present in aqueous 
solution at different pH. 
Organic acids pKa 
Predominant species in solution at pH 
4.0 4.5  5.0 
Citric acid  3.13, 4.76, 6.40 CIT− CIT− CIT2− 
Succinic acid  4.20, 5.60 SUC0 SUC− SUC− 
Lactic acid  3.86 LAC− LAC− LAC− 
4.3 Summary 
The dissolution rate of OCP-SUC, OCP-CIT, OCP-LAC, OCP and bone powders at pH 
4, 4.5 and 5.0 were measured. The nature of the metabolite incorporated into OCP has 
a very significant effect on dissolution rate, which is pH dependent. Thus, metabolite 
incorporation in bone can be expected to have a significant effect in the remodelling 
process. 
Interestingly, for the compounds containing citrate and lactate, the predominant 
metabolites in bone, the pH dependence of dissolution rate is very small. The 
incorporated metabolic acids for these two composites are hydroxyl-acids, and they 
may have involved in mechanisms that buffer the dissolution of the mineral against 
changes in pH between pH 4.0 – 5.0. Since the resorption process is taking place at pH 
4.5, the buffering property of the metabolites within the mineral may prevent 
derangement of the resorption process by slight variations in local pH. This is important 
as insufficient or excessive resorption would lead to over-mineralisation or porous 
mineral structure, which both will render bone weaker and more fragile and unsuitable 
for its function. 
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Chapter 5:                                
Conclusions and Future Work 
 
Since the first structural model of bone mineral was proposed by Dejong in 1926,94 the 
models of bone mineral have been developed over time to accommodate new findings. 
However, in spite of the intensive research on the subject, the precise molecular 
structure of the bone mineral is still an open question. The incorporation of citrate 
within the mineral structure introduced by Davies et al.11 provided a more 
comprehensive structural model that could explain many experimental observations in 
terms of the mineral structure. The work carried out in this study has shown that many 
different small metabolic molecules can potentially be readily incorporated into the 
hydrated layer of the mineral structure. The dissolution experiments have indicated that 
these metabolites have different effect on the solubility of the mineral, and the study 
suggest that bone diseases such as osteoporosis can be explained with chemical 
composition of the bone mineral, and any factors that would affect metabolism of bone 
cells may contribute to the local variation of the mineral composition. The molecular 
model constructed by DFT calculation shown a trend in which different size of 
metabolites could be incorporated into the calcium phosphate structure. This model 
increases our understanding of the properties of such system and help in the explanation 
of many observed results. The trapping of small metabolic molecules could be 
originated during the mineralisation process, where these carboxylates are excellent in 
chelating to the calcium cation, and could facilitate the delivering of the calcium ions 
to the mineralisation sites, and stuck in place as the ions mineralise. This theory is 
consistent with all the current theory of biomineralisation. 
There are two possible directions for the future work of this study. The first one is to 
further investigate of the presence of metabolite within the mineral phase, and the effect 
of metabolites inside mineral structure; and the second possibility is to explore the 
application of OCP-metabolite composite in medical applications such as bone implant 
or used for drug delivery. 
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The dissolution rate measured in this study are performed in vitro, and in the absence 
of the organic framework. In order for the data to be useful and draw link to the cause 
of bone disease such as osteoporosis, a study that closely resembles the in vivo system 
should require. The first step towards the goal can be a study of the resorption of the 
composites by actual osteoclasts, particularly the comparison of volume of the cavity 
which the cell can dissolve on different composites. Such data will bring us yet another 
step closer to confirming the hypothesis this study proposed, and also provide biological 
compatibility data of the material to osteoclasts which is valuable if OCP-metabolite 
composites are used for implants. Collagen organic framework is very important in the 
mechanical properties of the bone tissue, and also crucial in the mineralisation process. 
The experimental protocols that could enable infusion of organic/mineral composites 
will be very important. The organic frameworks can be designed polymers that enables 
OCP-metabolite to be deposited within the structure, then study of osteoclasts and 
osteoblasts on this material will mimic the remodelling process of the bone tissue. The 
experimental protocol itself may also provide insights to the formation of biomineral. 
This work has shown that the metabolites which are relatively low concentration in the 
bone will have big impact in the strength and morphology of the bone tissue. It would 
be beneficial if there is a highly sensitive methodology which can identify and quantify 
the amount of metabolic acids are present in bone mineral, and a study which compares 
healthy and diseased bones could bring insight how does different metabolite 
composition in mineral contribute to different bone disease. Such methodology can be 
removing the organic part of bone without destruction of the mineral phase, and left the 
pure mineral for further examination, or as technology/science advance, there solution-
state NMR could have pulse sequence to detect small molecules in much lower 
concentration, and with databanks to identify them. On the other hand, if large amount 
of bone samples can be collected (different ages, different health conditions), a simple 
protocol such as the leaching experiment used in this study could be used to create 
fingerprint spectra and by cross examine the difference between samples, critical 
component that causing disease may be identified. 
The OCP-metabolites can also investigated in its medical use. Besides used as possible 
implant for bone due to the similar resemblance between OCP-metabolites and bone 
mineral, the compound may also play a role as possible drug delivery compound. The 
OCP-metabolite composites synthesized in this work have different d100 spacings, 
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depending on the size of the metabolite, and the difference in spacing is mainly in the 
hydrated layer. The difference in the size of the hydrated layer between the different 
composites may be very useful in designing implants and grafts appropriate for a variety 
of purposes. The size of hydrated layer would affect the diffusion behaviour of 
molecules and control the size of the molecules that pass through the hydrated channel. 
Thus, the OCP-metabolite materials synthesised here may be used for drug delivery to 
the implant site by trap drug molecule inside the hydrated layer during synthesise, and 
release upon the resorption by osteoclasts.  
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